BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DeLeve LD, Valla DC, Garcia-Tsao G;  American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764. [PMID: 19399912 DOI: 10.1002/hep.22772] [Cited by in Crossref: 599] [Cited by in F6Publishing: 436] [Article Influence: 49.9] [Reference Citation Analysis]
Number Citing Articles
1 Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol 2014;20:384-91. [PMID: 25548745 DOI: 10.3350/cmh.2014.20.4.384] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
2 Lai Q, Spoletini G, Pinheiro RS, Melandro F, Guglielmo N, Lerut J. From portal to splanchnic venous thrombosis: What surgeons should bear in mind. World J Hepatol 2014; 6(8): 549-558 [PMID: 25232448 DOI: 10.4254/wjh.v6.i8.549] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
3 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol 2019; 25(31): 4437-4451 [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
4 Yang S, Wu J, Lei S. CT Features of Hepatic Veno-occlusive Disease. Academic Radiology 2018;25:328-37. [DOI: 10.1016/j.acra.2017.10.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
5 Licinio R, Principi M, Losurdo G, Castellaneta NM, Ierardi E, Di Leo A. Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes? ScientificWorldJournal 2014;2014:895839. [PMID: 25614899 DOI: 10.1155/2014/895839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Goel RM, Johnston EL, Patel KV, Wong T. Budd-Chiari syndrome: investigation, treatment and outcomes. Postgrad Med J 2015;91:692-7. [PMID: 26494427 DOI: 10.1136/postgradmedj-2015-133402] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
7 Wang CY, Wei LQ, Niu HZ, Gao WQ, Wang T, Chen SJ. Agitation thrombolysis combined with catheter-directed thrombolysis for the treatment of non-cirrhotic acute portal vein thrombosis. World J Gastroenterol 2018; 24(39): 4482-4488 [PMID: 30357003 DOI: 10.3748/wjg.v24.i39.4482] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
8 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
9 Musumba CO. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy. Aliment Pharmacol Ther 2013;38:1025-37. [PMID: 24099468 DOI: 10.1111/apt.12490] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
10 del Carmen Manzano-robleda M, Barranco-fragoso B, Uribe M, Méndez-sánchez N. Portal vein thrombosis: What is new? Annals of Hepatology 2015;14:20-7. [DOI: 10.1016/s1665-2681(19)30797-5] [Cited by in Crossref: 34] [Article Influence: 5.7] [Reference Citation Analysis]
11 Di Nisio M, Lee AYY, Carrier M, Liebman HA, Khorana AA; the Subcommittee on Haemostasis and Malignancy. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2015;13:880-3. [DOI: 10.1111/jth.12883] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 11.0] [Reference Citation Analysis]
12 Peng C, Zhang X, Zhang F, Liu L, Shao Y, Xiang X, Zhang W, Xiao J, Wang Y, Zhang B, Yin Q, Song Y, Mo Z, Zou X, Zhang M, Zhuge Y. Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective multicenter cohort study. European Journal of Gastroenterology & Hepatology 2020;32:1168-78. [DOI: 10.1097/meg.0000000000001630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hugenholtz GC, Northup PG, Porte RJ, Lisman T. Is there a rationale for treatment of chronic liver disease with antithrombotic therapy? Blood Rev. 2015;29:127-136. [PMID: 25468718 DOI: 10.1016/j.blre.2014.10.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
14 Aliev MM, Yuldashev RZ, Adilova GS, Yusupaileva GA. Renal blood flow before and after portosystemic shunt in children with portal hypertension. Pediatr Surg Int. 2014;30:295-299. [PMID: 24448909 DOI: 10.1007/s00383-014-3463-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Andreu-Ruiz A, Sanmartín-Monzó JL. Acute idiopathic portal, mesenteric and splenic vein thrombosis. Locoregional fibrinolytic therapy. Med Intensiva. 2015; Dec 24. [Epub ahead of print]. [PMID: 26725106 DOI: 10.1016/j.medin.2015.11.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Mo A, Testro A, French J, Robertson M, Angus P, Grigg A. Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome. Intern Med J. 2017;47:1361-1367. [PMID: 28675622 DOI: 10.1111/imj.13544] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
17 Marot A, Barbosa J, Duran R, Deltenre P, Denys A. Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion. Diagnostic and Interventional Imaging 2019;100:147-56. [DOI: 10.1016/j.diii.2018.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
18 Qi X, Wang J, Ren W, Bai M, Yang M, Han G, Fan D. Familial Budd-Chiari Syndrome in China: A Systematic Review of the Literature. ISRN Hepatol. 2013;2013:7. [PMID: 27335832 DOI: 10.1155/2013/763508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Richardson PG, Ho VT, Giralt S, Arai S, Mineishi S, Cutler C, Antin JH, Stavitzski N, Niederwieser D, Holler E. Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease. Ther Adv Hematol. 2012;3:253-265. [PMID: 23606935 DOI: 10.1177/2040620712441943] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
20 Corbacioglu S, Kernan N, Lehmann L, Brochstein J, Revta C, Grupp S, Martin P, Richardson PG. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Expert Rev Hematol 2012;5:291-302. [PMID: 22780209 DOI: 10.1586/ehm.12.18] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
21 Falcão CK, Fagundes GC, Lamos GC, Felipe-Silva A, Lovisolo SM, Martines JA, de Campos FP. Budd-Chiari Syndrome: an unnoticed diagnosis. Autops Case Rep 2015;5:17-25. [PMID: 26484330 DOI: 10.4322/acr.2015.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences1: Hypercoagulability in cirrhosis. Journal of Thrombosis and Haemostasis 2011;9:1713-23. [DOI: 10.1111/j.1538-7836.2011.04429.x] [Cited by in Crossref: 164] [Cited by in F6Publishing: 131] [Article Influence: 16.4] [Reference Citation Analysis]
23 Qi X. Portal Vein Thrombosis: Recent Advance. Adv Exp Med Biol. 2017;906:229-239. [PMID: 27638623 DOI: 10.1007/5584_2016_118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
24 Hoekstra J, Seijo S, Rautou P, Ducarme G, Boudaoud L, Luton D, Alijotas-reig J, Casellas-caro M, Condat B, Bresser E, Thabut D, Larroque B, Gárcia-pagán J, Janssen H, Valla D, Plessier A. Pregnancy in women with portal vein thrombosis: Results of a multicentric European study on maternal and fetal management and outcome. Journal of Hepatology 2012;57:1214-9. [DOI: 10.1016/j.jhep.2012.07.034] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
25 Søgaard KK, Adelborg K, Darvalics B, Horváth-Puhó E, Beyer-Westendorf J, Ageno W, Sørensen HT. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study. Lancet Haematol 2018;5:e441-9. [PMID: 30201587 DOI: 10.1016/S2352-3026(18)30133-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
26 Congly SE, Lee SS. Portal vein thrombosis: should anticoagulation be used? Curr Gastroenterol Rep. 2013;15:306. [PMID: 23314804 DOI: 10.1007/s11894-012-0306-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
27 Stotts MJ, Davis JPE, Shah NL. Coagulation testing and management in liver disease patients. Curr Opin Gastroenterol 2020;36:169-76. [PMID: 32141899 DOI: 10.1097/MOG.0000000000000635] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Yonal I, Pinarbası B, Hindilerden F, Hancer VS, Nalcaci M, Kaymakoglu S, Diz-Kucukkaya R. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis 2012;34:388-96. [PMID: 22569900 DOI: 10.1007/s11239-012-0738-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Riva N, Ageno W. Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis. Vasc Med 2017;22:529-40. [PMID: 29202678 DOI: 10.1177/1358863X17734057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Shatzel JJ, O'Donnell M, Olson SR, Kearney MR, Daughety MM, Hum J, Nguyen KP, DeLoughery TG. Venous thrombosis in unusual sites: A practical review for the hematologist. Eur J Haematol 2019;102:53-62. [PMID: 30267448 DOI: 10.1111/ejh.13177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
31 Cheng D, Xu H, Lu Z, Hua R, Qiu H, Du H, Xu X, Zhang J. Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: A single-center study: Budd-Chiari syndrome in Chinese patients. J Gastroenterol Hepatol 2013;28:1061-7. [DOI: 10.1111/jgh.12140] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
32 Handa P, Crowther M, Douketis JD. Portal vein thrombosis: a clinician-oriented and practical review. Clin Appl Thromb Hemost. 2014;20:498-506. [PMID: 23364162 DOI: 10.1177/1076029612473515] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
33 Harding DJ, Perera MTP, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 2015; 21(22): 6769-6784 [PMID: 26078553 DOI: 10.3748/wjg.v21.i22.6769] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
34 Kan X, Ye J, Rong X, Lu Z, Li X, Wang Y, Yang L, Xu K, Song Y, Hou X. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome. Sci Rep. 2016;6:37998. [PMID: 27897243 DOI: 10.1038/srep37998] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
35 Respess M, O'Toole TE, Taeymans O, Rogers CL, Johnston A, Webster CR. Portal vein thrombosis in 33 dogs: 1998-2011. J Vet Intern Med 2012;26:230-7. [PMID: 22369249 DOI: 10.1111/j.1939-1676.2012.00893.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
36 Alzubaidi S, Patel I, Saini A, Knuttinen G, Naidu S, Kriegshuaser S, Albadawi H, Oklu R. Current concepts in portal vein thrombosis: etiology, clinical presentation and management. Abdom Radiol 2019;44:3453-62. [DOI: 10.1007/s00261-019-02174-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
37 Zheng Z, Shi L, Sheng Y, Zhang J, Lu B, Ji L. Chlorogenic acid suppresses monocrotaline-induced sinusoidal obstruction syndrome: The potential contribution of NFκB, Egr1, Nrf2, MAPKs and PI3K signals. Environmental Toxicology and Pharmacology 2016;46:80-9. [DOI: 10.1016/j.etap.2016.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
38 Schultheiß M, Bettinger D, Thimme R. Nonsurgical Therapeutic Options in Portal Vein Thrombosis. Viszeralmedizin 2014;30:388-92. [PMID: 26288606 DOI: 10.1159/000369848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 39.5] [Reference Citation Analysis]
40 Spaander MCW, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FWG, Janssen HLA. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 2013;11:452-9. [DOI: 10.1111/jth.12121] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
41 Pavri TM, Herbst A, Reddy R, Forde KA. Budd-Chiari syndrome: A single-center experience. World J Gastroenterol 2014; 20(43): 16236-16244 [PMID: 25473178 DOI: 10.3748/wjg.v20.i43.16236] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
42 Shrestha SM, Kage M, Lee BB. Hepatic vena cava syndrome: New concept of pathogenesis. Hepatol Res. 2017;47:603-615. [PMID: 28169486 DOI: 10.1111/hepr.12869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Borja A, Xing W, Lymen E, Azucena B, Sule AA. Thrombus Resolution in Two Patients with Portal Vein Thrombosis without Anticoagulation: Do We Need to Anticoagulate Patients with Portal Vein Thrombosis? Int J Angiol 2016;25:e93-6. [PMID: 28031666 DOI: 10.1055/s-0034-1395980] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Valeriani E, Riva N, Di Nisio M, Ageno W. Splanchnic Vein Thrombosis: Current Perspectives. Vasc Health Risk Manag 2019;15:449-61. [PMID: 31695400 DOI: 10.2147/VHRM.S197732] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
45 Sato K, Sakamoto Y, Sakai M, Ishikawa C, Nakazawa M, Cheng CJ, Watari T, Nakayama T. Diagnostic utility of computed tomographic angiography in dogs with portal vein thrombosis. J Vet Med Sci 2020;82:1421-7. [PMID: 32814748 DOI: 10.1292/jvms.20-0226] [Reference Citation Analysis]
46 Sarin SK, Philips CA, Kamath PS, Choudhury A, Maruyama H, Nery FG, Valla DC. Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis. Gastroenterology. 2016;151:574-577. [PMID: 27575821 DOI: 10.1053/j.gastro.2016.08.033] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
47 Ingviya T, Wasuwanich P, Scheimann AO, Felix G, Laengvejkal P, Vasilescu A, Imteyaz H, Seaberg EC, Karnsakul W. Clinical Predictors of Morbidity and Mortality in Hospitalized Pediatric Patients With Ascites. J Pediatr Gastroenterol Nutr 2021;73:86-92. [PMID: 33633084 DOI: 10.1097/MPG.0000000000003104] [Reference Citation Analysis]
48 Mancuso A. TIPS for Budd-Chiari syndrome: time to anticipate treatment. Liver Int. 2014;34:e325. [PMID: 24650135 DOI: 10.1111/liv.12544] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
49 Chen H, He C, Lv Y, Fan J, Tang S, Niu J, Yuan J, Luo B, Guo W, Yin Z, Han G. Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstruction. J Gastroenterol Hepatol 2020;35:1049-56. [PMID: 31677186 DOI: 10.1111/jgh.14902] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Cuervo H, Nielsen CM, Simonetto DA, Ferrell L, Shah VH, Wang RA. Endothelial notch signaling is essential to prevent hepatic vascular malformations in mice. Hepatology 2016;64:1302-16. [PMID: 27362333 DOI: 10.1002/hep.28713] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
51 Obata F, Abe H, Murakami T, Ueda S, Inagaki T, Minato M, Ono H, Nishimura K, Shibata E, Tamaki M, Kishi F, Kishi S, Nagai K, Doi T. Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis. CEN Case Rep 2019;8:134-8. [PMID: 30721455 DOI: 10.1007/s13730-019-00381-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Gupta S, Hidalgo J, Singh B, Iyer A, Yang Y, Short A, Singh S, Bhatt H, Gupta S. Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review. Cureus 2021;13:e16922. [PMID: 34367844 DOI: 10.7759/cureus.16922] [Reference Citation Analysis]
53 Rubbia-Brandt L. Sinusoidal obstruction syndrome. Clin Liver Dis. 2010;14:651-668. [PMID: 21055688 DOI: 10.1016/j.cld.2010.07.009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
54 Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein. Hepatobiliary Pancreat Dis Int. 2018;17:517-523. [PMID: 30262421 DOI: 10.1016/j.hbpd.2018.09.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
55 Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis. 2009;1:e2009014. [PMID: 21415954 DOI: 10.4084/mjhid.2009.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
56 Qi X, Guo X, Fan D. Difference in Budd-Chiari syndrome between the west and china: CORRESPONDENCE. Hepatology 2015;62:656-656. [DOI: 10.1002/hep.27628] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
57 Sweetser S, Razumilava N, Kamath PS. A bad streak. Gastroenterology 2012;142:432-3, 677. [PMID: 22285360 DOI: 10.1053/j.gastro.2011.07.031] [Reference Citation Analysis]
58 Kawata E, Siew DA, Payne JG, Louzada M, Kovacs MJ, Lazo-Langner A. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes. Thromb Res 2021;202:90-5. [PMID: 33798804 DOI: 10.1016/j.thromres.2021.03.018] [Reference Citation Analysis]
59 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
60 Mancuso A. Limits of Evidence Based Medicine for rare diseases: The case of Budd-Chiari syndrome. Digestive and Liver Disease 2016;48:689. [DOI: 10.1016/j.dld.2016.02.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
61 Luo X, Nie L, Zhou B, Yao D, Ma H, Jiang M, Zhang H, Li X. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma. Gastroenterol Res Pract 2014;2014:659726. [PMID: 24868203 DOI: 10.1155/2014/659726] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
62 Bolus C, Yamada R, Alshora S, Hannegan C, Anderson B. Transarterial embolization of a hepatic arteriovenous malformation in an infant using Onyx: a case report and review of the differential diagnosis imaging findings. J Radiol Case Rep 2014;8:33-42. [PMID: 25426243 DOI: 10.3941/jrcr.v8i8.2171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
63 Yeoh SW, Kok HK. Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. J Dig Dis 2021. [PMID: 34323378 DOI: 10.1111/1751-2980.13035] [Reference Citation Analysis]
64 Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013;58:1776-1780. [PMID: 23314858 DOI: 10.1007/s10620-012-2548-y] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 11.1] [Reference Citation Analysis]
65 Gulamhusein AF, Kamath PS. The epidemiology and pathogenesis of gastrointestinal varices. Techniques in Gastrointestinal Endoscopy 2017;19:62-8. [DOI: 10.1016/j.tgie.2017.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Williams C, Stewart E, Conzen KD, Wolf S, Tran TT. Dabigatran Reversal With Idarucizumab in 2 Patients With Portal Vein Thrombosis Undergoing Orthotopic Liver Transplantation. Semin Cardiothorac Vasc Anesth 2021;25:200-7. [DOI: 10.1177/1089253220982183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP. Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis: Similarities and Differences. Arterioscler Thromb Vasc Biol 2011;31:485-93. [DOI: 10.1161/atvbaha.110.213371] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
68 Qi X, Yang Z, De Stefano V, Fan D. Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studies: MTHFR mutation and homocysteine in BCS and PVT. Hepatol Res 2014;44:E480-98. [DOI: 10.1111/hepr.12348] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
69 Allison MG, Shanholtz CB, Sachdeva A. Hematological Issues in Liver Disease. Crit Care Clin 2016;32:385-96. [PMID: 27339678 DOI: 10.1016/j.ccc.2016.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
70 Barcelos STA, Dall'Oglio VM, de Araújo A, Cerski CTS, Álvares-da-Silva MR. Sinusoidal obstruction syndrome secondary the intake of Senecio brasiliensis: A case report. Ann Hepatol 2021;20:100138. [PMID: 31606353 DOI: 10.1016/j.aohep.2019.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol. 2014;11:435-446. [PMID: 24686266 DOI: 10.1038/nrgastro.2014.36] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 11.7] [Reference Citation Analysis]
72 Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013;125:200-219. [PMID: 23579878 DOI: 10.1007/s00508-013-0337-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
73 Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J. 2015;3:489-500. [PMID: 26668741 DOI: 10.1177/2050640615582293] [Cited by in Crossref: 47] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
74 Almashhrawi AA, Ahmed KT, Rahman RN, Hammoud GM, Ibdah JA. Liver diseases in pregnancy: Diseases not unique to pregnancy. World J Gastroenterol 2013; 19(43): 7630-7638 [PMID: 24282352 DOI: 10.3748/wjg.v19.i43.7630] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
75 Ochs A. [Acute hepatic vascular complications]. Internist (Berl). 2011;52:795-796, 798-800, 802-803. [PMID: 21667100 DOI: 10.1007/s00108-010-2795-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
76 Shim M, Yang TY, Cho NG, Woo A, Kim E, Park K, Lee JH, Lee YB, Hwang SG, Rim KS, Park H. Hepatic Infarction Caused by Portal Vein Thrombophlebitis Misdiagnosed as Infiltrative Hepatic Malignancy with Neoplastic Thrombus. Korean J Gastroenterol 2016;68:156-60. [PMID: 27646586 DOI: 10.4166/kjg.2016.68.3.156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Berzigotti A, García-criado Á, Darnell A, García-pagán J. Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol 2014;11:308-16. [DOI: 10.1038/nrgastro.2013.258] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 6.9] [Reference Citation Analysis]
78 Mammen S, Keshava SN, Kattiparambil S. Acute Portal Vein Thrombosis, No Longer a Contraindication for Transjugular Intrahepatic Porto-Systemic Shunt (TIPS) Insertion. J Clin Exp Hepatol. 2015;5:259-261. [PMID: 26628844 DOI: 10.1016/j.jceh.2014.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
79 Hicks AM, DeRosa A, Raj M, Do R, Yu KH, Lowery MA, Varghese A, O'Reilly EM. Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review. Clin Colorectal Cancer 2018;17:e207-16. [PMID: 29306522 DOI: 10.1016/j.clcc.2017.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
80 Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond) 2017;17:212-9. [PMID: 28572222 DOI: 10.7861/clinmedicine.17-3-212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Kreimeyer S, Grenacher L. [Diffuse and vascular hepatic diseases]. Radiologe 2011;51:704-13. [PMID: 21805255 DOI: 10.1007/s00117-010-2129-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Oguslu U, Uyanik SA, Cenkeri HÇ, Atli E, Yilmaz B, Gümüş B. Transhepatic Pharmacomechanical Thrombectomy of Symptomatic Acute Noncirrhotic, Nonmalignant Portomesenteric Venous Thrombosis: Midterm Results. AJR Am J Roentgenol 2021;217:418-25. [PMID: 34036807 DOI: 10.2214/AJR.20.23150] [Reference Citation Analysis]
83 Goldhar HA, O'Meara P, Castellucci LA. A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditis. BMJ Case Rep 2019;12:e227450. [PMID: 31092489 DOI: 10.1136/bcr-2018-227450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
84 Ruan J, Gao H, Li N, Xue J, Chen J, Ke C, Ye Y, Fu PP, Zheng J, Wang J, Lin G. Blood Pyrrole-Protein Adducts--A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2015;33:404-21. [PMID: 26398275 DOI: 10.1080/10590501.2015.1096882] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
85 Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010;31:366-374. [PMID: 19863496 DOI: 10.1111/j.1365-2036.2009.04182.x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 159] [Article Influence: 14.5] [Reference Citation Analysis]
86 Inchingolo R, Posa A, Mariappan M, Tibana TK, Nunes TF, Spiliopoulos S, Brountzos E. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review. World J Gastroenterol 2020; 26(34): 5060-5073 [PMID: 32982109 DOI: 10.3748/wjg.v26.i34.5060] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, Chen F, Mangat K, Elias E, Olliff S. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther. 2014;39:864-872. [PMID: 24611957 DOI: 10.1111/apt.12668] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
88 Buscarini E, Leandro G, Conte D, Danesino C, Daina E, Manfredi G, Lupinacci G, Brambilla G, Menozzi F, De Grazia F, Gazzaniga P, Inama G, Bonardi R, Blotta P, Forner P, Olivieri C, Perna A, Grosso M, Pongiglione G, Boccardi E, Pagella F, Rossi G, Zambelli A. Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia. Dig Dis Sci 2011;56:2166-78. [PMID: 21290179 DOI: 10.1007/s10620-011-1585-2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
89 Zeng Q, Fu QN, Li FH, Wang XH, Liu H, Zhao Y. Early initiation of argatroban therapy in the management of acute superior mesenteric venous thrombosis. Exp Ther Med. 2017;13:1526-1534. [PMID: 28413504 DOI: 10.3892/etm.2017.4103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
90 Buzzetti E, Parikh PM, Gerussi A, Tsochatzis E. Gender differences in liver disease and the drug-dose gender gap. Pharmacol Res 2017;120:97-108. [PMID: 28336373 DOI: 10.1016/j.phrs.2017.03.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
91 Klinger C, Riecken B, Schmidt A, De Gottardi A, Meier B, Bosch J, Caca K. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Digestive and Liver Disease 2017;49:1345-52. [DOI: 10.1016/j.dld.2017.05.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
92 Fontanilla T, Hernando CG, Claros JCV, Bautista G, Minaya J, del Carmen Vega M, Piazza A, Méndez S, Rodriguez C, Arangüena RP. Acoustic Radiation Force Impulse Elastography and Contrast-Enhanced Sonography of Sinusoidal Obstructive Syndrome (Veno-occlusive Disease): Preliminary Results. Journal of Ultrasound in Medicine 2011;30:1593-8. [DOI: 10.7863/jum.2011.30.11.1593] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
93 Rodríguez-Leal GA, Morán S, Corona-Cedillo R, Brom-Valladares R. Portal vein thrombosis with protein C-S deficiency in a non-cirrhotic patient. World J Hepatol 2014; 6(7): 532-537 [PMID: 25068006 DOI: 10.4254/wjh.v6.i7.532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
94 Gioia S, Nardelli S, Ridola L, Riggio O. Causes and Management of Non-cirrhotic Portal Hypertension​. Curr Gastroenterol Rep 2020;22:56. [PMID: 32940785 DOI: 10.1007/s11894-020-00792-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
95 Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3:18. [PMID: 28930128 DOI: 10.3390/medicines3030018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 9.6] [Reference Citation Analysis]
96 Ki M, Choi HY, Kim K, Kim BH, Jang ES, Jeong S. Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study. Liver Int 2016;36:1067-73. [DOI: 10.1111/liv.13008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
97 Westbrook RH, Lea NC, Mohamedali AM, Smith AE, Orr DW, Roberts LN, Heaton ND, Wendon JA, O’Grady JG, Heneghan MA. Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation. Liver Transpl. 2012;18:819-827. [PMID: 22467227 DOI: 10.1002/lt.23443] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
98 Zarrouk M, Salim S, Elf J, Gottsäter A, Acosta S. Testing for thrombophilia in mesenteric venous thrombosis - Retrospective original study and systematic review. Best Pract Res Clin Gastroenterol 2017;31:39-48. [PMID: 28395787 DOI: 10.1016/j.bpg.2016.11.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
99 Fan J, Wang Q, Luo B, Chen H, Wang Z, Niu J, Yuan J, Yuan X, Bai W, He C, Guo W, Li K, Yin Z, Fan D, Han G. Prevalence of prothrombotic factors in patients with Budd–Chiari syndrome or non‐cirrhotic nonmalignant portal vein thrombosis: A hospital‐based observational study. Journal of Gastroenterology and Hepatology 2020;35:1215-22. [DOI: 10.1111/jgh.14925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
100 Fortea JI, Carrera IG, Puente Á, Cuadrado A, Huelin P, Tato CÁ, Fernández PÁ, Montes MDRP, Céspedes JN, López AB, Sanchez FJG, Hoyos ML, Crespo J, Fábrega E. Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders. J Clin Med 2020;9:E2822. [PMID: 32878264 DOI: 10.3390/jcm9092822] [Reference Citation Analysis]
101 Wang X, Luo X, Zhao M, Song J, Li X, Yang L. Prognostic Factors for Acute Transjugular Intrahepatic Portosystemic Shunt Occlusion Using Expanded Polytetrafluoroethylene-Covered Stent. Dig Dis Sci 2020;65:3032-9. [PMID: 31853780 DOI: 10.1007/s10620-019-06008-4] [Reference Citation Analysis]
102 Mancuso A. Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist's Perspective. J Transl Int Med. 2017;5:194-199. [PMID: 29340275 DOI: 10.1515/jtim-2017-0033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
103 Fujiyama S, Saitoh S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Suzuki F, Arase Y, Ikeda K, Kumada H. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. BMC Gastroenterol 2017;17:112. [PMID: 29070023 DOI: 10.1186/s12876-017-0668-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
104 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018;30:1187-93. [PMID: 30074506 DOI: 10.1097/MEG.0000000000001219] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 11.5] [Reference Citation Analysis]
105 Qi X, Han G, He C, Yin Z, Zhang H, Wang J, Xia J, Cai H, Yang Z, Bai M, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit 2012;18:HY37-41. [PMID: 22847208 DOI: 10.12659/msm.883252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
106 Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-91. [PMID: 31584464 DOI: 10.1097/MEG.0000000000001559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
107 John B, Konjeti R, Aggarwal A, Lopez R, Atreja A, Miller C, Zein N, Carey W. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Annals of Hepatology 2013;12:952-8. [DOI: 10.1016/s1665-2681(19)31301-8] [Cited by in Crossref: 65] [Article Influence: 8.1] [Reference Citation Analysis]
108 Entezari P, Riaz A, Thornburg B, Salem R. Percutaneous Ultrasound-Guided Superior and Inferior Mesenteric Vein Access for Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt: A Case Series. Cardiovasc Intervent Radiol 2021;44:496-9. [PMID: 33230650 DOI: 10.1007/s00270-020-02713-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
109 Stine JG, Northup PG. Coagulopathy Before and After Liver Transplantation: From the Hepatic to the Systemic Circulatory Systems. Clin Liver Dis 2017;21:253-74. [PMID: 28364812 DOI: 10.1016/j.cld.2016.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
110 Chen H, Liu L, Qi X, He C, Wu F, Fan D, Han G. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016;28:82-89. [PMID: 26513611 DOI: 10.1097/meg.0000000000000482] [Cited by in Crossref: 60] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
111 Potthoff A, Attia D, Pischke S, Mederacke I, Beutel G, Rifai K, Deterding K, Heiringhoff K, Klempnauer J, Strassburg CP, Manns MP, Bahr MJ. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms. Liver Int 2015;35:2042-9. [PMID: 25736096 DOI: 10.1111/liv.12816] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
112 Devarbhavi H, Murali AR. Safety of Ascitic Paracentesis in Patients with Budd-Chiari Syndrome on Oral Anticoagulation and Elevated International Normalized Ratio. J Clin Exp Hepatol 2015;5:310-3. [PMID: 26900272 DOI: 10.1016/j.jceh.2015.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Kwa CX, Tan VK, Ong HS. Anticoagulation in the treatment of portovenous emboli after cyanoacrylate injection for a bleeding gastric varix. Singapore Med J 2015;56:e14-6. [PMID: 25640106 DOI: 10.11622/smedj.2015016] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
114 Abdel-Razik A, Mousa N, Elhelaly R, Tawfik A. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system. Eur J Gastroenterol Hepatol 2015;27:585-92. [PMID: 25769098 DOI: 10.1097/MEG.0000000000000325] [Cited by in Crossref: 45] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
115 Lin M, Zhang F, Wang Y, Zhang B, Zhang W, Zou X, Zhang M, Zhuge Y. Liver cirrhosis caused by chronic Budd-Chiari syndrome. Medicine (Baltimore) 2017;96:e7425. [PMID: 28834866 DOI: 10.1097/MD.0000000000007425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
116 Valla DC, Cazals-Hatem D. Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts. Virchows Arch. 2018;473:3-13. [PMID: 29572606 DOI: 10.1007/s00428-018-2331-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
117 Zhou WJ, Cui YF, Zu MH, Zhang QQ, Xu H. Budd-Chiari Syndrome in Young Chinese: Clinical Characteristics, Etiology and Outcome of Recanalization from a Single Center. Cardiovasc Intervent Radiol 2016;39:557-65. [PMID: 26811088 DOI: 10.1007/s00270-016-1295-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
118 Ageno W, Dentali F, Squizzato A. How I treat splanchnic vein thrombosis. Blood 2014;124:3685-91. [DOI: 10.1182/blood-2014-07-551515] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
119 Mmbaga N, Torrealday S, McCarthy S, Rackow BW. Acute portal vein thrombosis complicating in vitro fertilization. Fertil Steril 2012;98:1470-3. [PMID: 22963807 DOI: 10.1016/j.fertnstert.2012.08.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
120 Luo X, Wang Z, Tsauo J, Zhou B, Zhang H, Li X. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS vs Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding. Radiology. 2015;276:286-293. [PMID: 25759969 DOI: 10.1148/radiol.15141252] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
121 Kucukay F, Akdogan M, Bostanci EB, Ulus AT, Kucukay MB. Percutaneous Transluminal Angioplasty for Complete Membranous Obstruction of Suprahepatic Inferior Vena Cava: Long-Term Results. Cardiovasc Intervent Radiol 2016;39:1392-9. [PMID: 27272713 DOI: 10.1007/s00270-016-1394-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
122 Günther S, Perros F, Rautou P, Girerd B, Ghigna M, Cazals-hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D. Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease. The American Journal of Pathology 2019;189:1159-75. [DOI: 10.1016/j.ajpath.2019.02.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
123 Luo S, Chu J, Huang H, Yao K. Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids. Biomed Res Int 2018;2018:9804582. [PMID: 30009181 DOI: 10.1155/2018/9804582] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pagán JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-65. [PMID: 26684272 DOI: 10.1002/lt.24387] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 10.8] [Reference Citation Analysis]
125 Qi X, Han G, Yin Z, He C, Wang J, Guo W, Niu J, Zhang W, Bai M, Fan D. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci. 2012;57:1072-1082. [PMID: 22147244 DOI: 10.1007/s10620-011-1975-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
126 Mancuso A. Budd-chiari syndrome management: Timing of treatment is an open issue. Hepatology 2014;59:1213. [PMID: 23857382 DOI: 10.1002/hep.26619] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
127 Endo K, Oikawa T, Kakisaka K, Tamura A, Ehara S, Takikawa Y. The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients. Scandinavian Journal of Gastroenterology 2018;53:1340-6. [DOI: 10.1080/00365521.2018.1503327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
128 Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study. World J Gastroenterol 2017; 23(4): 629-637 [PMID: 28216969 DOI: 10.3748/wjg.v23.i4.629] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
129 Brunton NE, Wysokinski WE, Hodge DO, Vlazny DT, Houghton DE, Casanegra AI. Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes. Res Pract Thromb Haemost 2021;5:e12500. [PMID: 34027287 DOI: 10.1002/rth2.12500] [Reference Citation Analysis]
130 Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies. Eur J Intern Med. 2015;26:23-29. [PMID: 25566699 DOI: 10.1016/j.ejim.2014.12.002] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 14.0] [Reference Citation Analysis]
131 Gao H, Li N, Wang JY, Zhang SC, Lin G. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Dig Dis. 2012;13:33-39. [PMID: 22188914 DOI: 10.1111/j.1751-2980.2011.00552.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 8.1] [Reference Citation Analysis]
132 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-398. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 101] [Cited by in F6Publishing: 77] [Article Influence: 14.4] [Reference Citation Analysis]
133 Valla DC. [Thrombosis of abdominal veins]. Rev Med Interne 2012;33 Suppl 1:S25-9. [PMID: 22444527 DOI: 10.1016/j.revmed.2012.02.008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 Richardson PG, Corbacioglu S, Ho VT, Kernan NA, Lehmann L, Maguire C, Maglio M, Hoyle M, Sardella M, Giralt S, Holler E, Carreras E, Niederwieser D, Soiffer R. Drug safety evaluation of defibrotide. Expert Opin Drug Saf 2013;12:123-36. [PMID: 23228043 DOI: 10.1517/14740338.2012.749855] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
135 Bissonnette J, Durand F, de Raucourt E, Ceccaldi PF, Plessier A, Valla D, Rautou PE. Pregnancy and vascular liver disease. J Clin Exp Hepatol 2015;5:41-50. [PMID: 25941432 DOI: 10.1016/j.jceh.2014.12.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
136 Gîrleanu I, Trifan A, Stanciu C, Sfarti C. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture. World J Gastroenterol 2018; 24(39): 4419-4427 [PMID: 30356984 DOI: 10.3748/wjg.v24.i39.4419] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
137 Vakil A, Guru P, Reddy DR, Iyer V. Diffuse cholangiocarcinoma presenting with hepatic failure and extensive portal and mesenteric vein thrombosis. BMJ Case Rep 2015;2015:bcr2014209171. [PMID: 26123458 DOI: 10.1136/bcr-2014-209171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Qi X, Wu F, Ren W, He C, Yin Z, Niu J, Bai M, Yang Z, Wu K, Fan D. Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature. Thromb Haemost. 2013;109:878-884. [PMID: 23447059 DOI: 10.1160/th12-10-0784] [Cited by in Crossref: 56] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
139 Cui SB, Shu RH, Yan SP, Wu H, Chen Y, Wang L, Zhu Q. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B. Eur J Gastroenterol Hepatol. 2015;27:914-919. [PMID: 25856686 DOI: 10.1097/meg.0000000000000351] [Cited by in Crossref: 50] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
140 Wang C, Wu X, Xie W, Ren X, Zhang W, Xu J. Quantitative Analysis of CT Images in Patients with Pyrrolizidine Alkaloid-Induced Sinusoidal Obstruction Syndrome. Sci Rep. 2019;9:2179. [PMID: 30778132 DOI: 10.1038/s41598-019-38669-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Shetty S, Ghosh K. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review. Thrombosis Research 2011;127:505-12. [DOI: 10.1016/j.thromres.2010.09.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
142 Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol. 2015;9:865-875. [PMID: 25754880 DOI: 10.1586/17474124.2015.1024224] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
143 Li W, Yu H, Qian A, Rong J, Zhang Y, Li X. Risk factors for and causes and treatment of recurrence of inferior vena cava type of Budd-Chiari syndrome after stenting in China: A retrospective analysis of a large cohort. Eur Radiol 2017;27:1227-37. [DOI: 10.1007/s00330-016-4482-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
144 Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, Nagao Y, Hashimoto N, Uehara H, Tomikawa M, Shirabe K, Maehara Y. Portal vein thrombosis in liver cirrhosis. World J Hepatol 2014; 6(2): 64-71 [PMID: 24575165 DOI: 10.4254/wjh.v6.i2.64] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
145 Pieri G, Theocharidou E, Burroughs AK. Liver in haematological disorders. Best Practice & Research Clinical Gastroenterology 2013;27:513-30. [DOI: 10.1016/j.bpg.2013.06.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
146 Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, Romano L, Balzano A. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2010;44:448-451. [PMID: 19730112 DOI: 10.1097/mcg.0b013e3181b3ab44] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
147 Ghaffar TYA, Elfaramawy AA, el Saied S, el Adawy M, Sakr MA, Zalata K. Hepatic Venous Outflow Obstruction Complicating Churg-Strauss Syndrome in a 5-year-old Child. Journal of Pediatric Gastroenterology & Nutrition 2011;52:217-8. [DOI: 10.1097/mpg.0b013e3181f507d7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Moini M, Onofrio F, Hansen BE, Adeyi O, Khalili K, Patel K. Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease. Sci Rep 2021;11:19275. [PMID: 34588540 DOI: 10.1038/s41598-021-98776-1] [Reference Citation Analysis]
149 Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crinò F, Maruzzelli L, Miraglia R, Floridia G, Vizzini G. Natural Course of Extrahepatic Nonmalignant Partial Portal Vein Thrombosis in Patients with Cirrhosis. Radiology 2012;265:124-32. [DOI: 10.1148/radiol.12112236] [Cited by in Crossref: 107] [Cited by in F6Publishing: 85] [Article Influence: 11.9] [Reference Citation Analysis]
150 Schirmer SH, Kiefer M, Kim YJ, Schneider G, Schäfers HJ, Zimmer V. Secondary Budd–Chiari syndrome complicating calcified right atrial thrombosis related to ventriculoatrial shunt. Clin Res Cardiol 2013;102:165-8. [DOI: 10.1007/s00392-012-0510-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Hunninghake J, Murray BP, Ferraro D, Gancayco J. Acute intestinal ischaemia from a portal vein thrombosis in a young female smoker on an oral contraceptive. BMJ Case Rep 2018;2018:bcr-2018-225135. [PMID: 30077981 DOI: 10.1136/bcr-2018-225135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Ren W, Qi X, Yang Z, Han G, Fan D. Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol. 2013;25:830-841. [PMID: 23411869 DOI: 10.1097/meg.0b013e32835eb8d4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
153 Wang H, Sun G, Zhang P, Zhang J, Gui E, Zu M, Jia E, Xu H, Xu L, Zhang J, Lu Z. JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients: JAK2 rs12343867 in Budd-Chiari syndrome. J Gastroenterol Hepatol 2014;29:208-14. [DOI: 10.1111/jgh.12379] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
154 Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ. Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis. Int J Hepatol. 2018;2018:8432781. [PMID: 29973997 DOI: 10.1155/2018/8432781] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
155 Alraies MC, Khan UA, Alraiyes AH, Auron M. Right atrium tumor thrombus. QJM 2013;106:679-80. [DOI: 10.1093/qjmed/hcs135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22-40. [PMID: 25941431 DOI: 10.1016/j.jceh.2014.12.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 56] [Article Influence: 13.7] [Reference Citation Analysis]
157 Martinelli I, De Stefano V, Mannucci PM. Inherited risk factors for venous thromboembolism. Nat Rev Cardiol 2014;11:140-56. [DOI: 10.1038/nrcardio.2013.211] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 10.1] [Reference Citation Analysis]
158 Llop E, Seijo S. [Treatment of non-cirrhotic, non-tumoural portal vein thrombosis]. Gastroenterol Hepatol 2016;39:403-10. [PMID: 26547613 DOI: 10.1016/j.gastrohep.2015.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
159 De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad SD, Vilgrain V, Hernandez-Gea V, Nery F, Plessier A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan JC; VALDIG group. Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol. 2019;4:399-411. [PMID: 30957754 DOI: 10.1016/s2468-1253(19)30047-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 42.0] [Reference Citation Analysis]
160 Riva N, Ageno W. Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions. J Clin Med 2020;9:E743. [PMID: 32164214 DOI: 10.3390/jcm9030743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
161 Ponziani FR, Zocco MA, Senzolo M, Pompili M, Gasbarrini A, Avolio AW. Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. Transplant Rev (Orlando). 2014;28:92-101. [PMID: 24582320 DOI: 10.1016/j.trre.2014.01.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
162 Qi X, Han G, Yin Z, He C, Guo W, Niu J, Wu K, Fan D. Cavernous vessels around a patent portal trunk in the liver hilum. Abdom Imaging 2012;37:422-30. [PMID: 21789553 DOI: 10.1007/s00261-011-9779-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
163 Fujiya K, Ganno H, Ando M, Chong JM. Clonorchis sinensis ova in bile juice cytology from a patient with severe hyperbilirubinemia and portal vein thrombosis. Diagn Cytopathol. 2016;44:223-225. [PMID: 26663478 DOI: 10.1002/dc.23400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
164 Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Maurizio LD, Bombardieri G, Cristofaro RD, Gaetano AMD, Landolfi R, Gasbarrini A. Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010; 16(2): 143-155 [PMID: 20066733 DOI: 10.3748/wjg.v16.i2.143] [Cited by in CrossRef: 148] [Cited by in F6Publishing: 112] [Article Influence: 13.5] [Reference Citation Analysis]
165 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 28.0] [Reference Citation Analysis]
166 Vishwajeet V, Purohit A, Kumar D, Vijayvergia P, Tripathi S, Kanchan T, Kothari N, Dutt N, Elhence PA, Bhatia PK, Nag VL, Garg MK, Misra S. Evaluation of liver histopathological findings of COVID-19 by minimally invasive autopsies. J Clin Exp Hepatol 2021. [PMID: 34312578 DOI: 10.1016/j.jceh.2021.07.004] [Reference Citation Analysis]
167 Jagtap N, Sharma M, Singh J, Tandan M, Rao PN, Gupta R, Lakhtakia S, Ramchandani M, Shah H, Mahesh Kumar T, Darishetty S, Rao GV, Reddy DN. Budd-Chiari syndrome: outcomes of endovascular intervention-A single-center experience. Indian J Gastroenterol 2017;36:209-16. [PMID: 28631134 DOI: 10.1007/s12664-017-0760-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
168 Villa E, De Maria N. Anticoagulation in cirrhosis. Liver Int. 2012;32:878-879. [PMID: 22672641 DOI: 10.1111/j.1478-3231.2012.02825.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
169 Ponziani FR, Zocco MA, Garcovich M, D’Aversa F, Roccarina D, Gasbarrini A. What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective. World J Gastroenterol 2012; 18(36): 5014-5020 [PMID: 23049208 DOI: 10.3748/wjg.v18.i36.5014] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
170 Lopez-Gomez M, Llop E, Puente A, Hernández Conde M, Ruiz P, Alvárez S, Martínez JL, Abad J, Fernández N, Perelló C, Fernández-Carrillo C, Ferre C, Trapero M, Fraga E, Crespo J, Calleja Panero JL. Non-malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors. Hepatol Res 2021. [PMID: 34324766 DOI: 10.1111/hepr.13703] [Reference Citation Analysis]
171 Yanik GA, Cooke KR, Ho VT, Richardson PG. Pulmonary and Hepatic Complications of Hematopoietic Cell Transplantation. In: Smith FO, Reaman GH, Racadio JM, editors. Hematopoietic Cell Transplantation in Children with Cancer. Berlin: Springer Berlin Heidelberg; 2014. pp. 77-102. [DOI: 10.1007/978-3-642-39920-6_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Buliarca A, Horhat A, Mocan T, Craciun R, Procopet B, Sparchez Z. Viscoelastic tests in liver disease: where do we stand now? World J Gastroenterol 2021; 27(23): 3290-3302 [PMID: 34163112 DOI: 10.3748/wjg.v27.i23.3290] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 李瑭, 王一娜, 尹琼丽, 叶小鸣. 中药一点红致肝小静脉闭塞病1例并文献复习. 世界华人消化杂志 2016; 24(1): 158-164 [DOI: 10.11569/wcjd.v24.i1.158] [Reference Citation Analysis]
174 Malikowski TM, Podboy AJ, Sweetser S. 57-Year-Old Woman With Abdominal Pain. Mayo Clin Proc 2017;92:1278-82. [PMID: 28647225 DOI: 10.1016/j.mayocp.2016.10.022] [Reference Citation Analysis]
175 Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis: Meta-analysis: JAK2V617F mutation in BCS and PVST. Alimentary Pharmacology & Therapeutics 2011;33:1087-103. [DOI: 10.1111/j.1365-2036.2011.04627.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
176 Shrestha SM. Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava). World J Hepatol 2015; 7(6): 874-884 [PMID: 25937864 DOI: 10.4254/wjh.v7.i6.874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
177 Fukuda A, Ogura Y, Kanazawa H, Mori A, Kawaguchi M, Takada Y, Uemoto S. Living donor liver transplantation for Budd-Chiari syndrome with hepatic inferior vena cava obstruction after open pericardial procedures. Surg Today. 2013;43:1180-1184. [PMID: 23188387 DOI: 10.1007/s00595-012-0440-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
178 Xiaoqing Z, Na L, Lili M, Jie C, Tiancheng L, Jian W, Shiyao C. Endoscopic Cyanoacrylate Injection with Lauromacrogol for Gastric Varices: Long-Term Outcomes and Predictors in a Retrospective Cohort Study. J Laparoendosc Adv Surg Tech A 2019;29:1135-43. [PMID: 31313965 DOI: 10.1089/lap.2019.0360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
179 Mancuso A. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Curr Hepatology Rep 2017;16:158-63. [DOI: 10.1007/s11901-017-0344-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Vernuccio F, Porrello G, Cannella R, Vernuccio L, Midiri M, Giannitrapani L, Soresi M, Brancatelli G. Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI. Clin Imaging 2021;70:33-45. [PMID: 33120287 DOI: 10.1016/j.clinimag.2020.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Fan X, Huang X, Hershman M, Zheng X, Jiang C, Yue B, Weisberg I. Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort. Eur J Gastroenterol Hepatol 2020;32:1160-7. [PMID: 31834054 DOI: 10.1097/MEG.0000000000001624] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Zhu TY, Zhou GH, Chen XH, Teng XD, Sun JH. Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review. J Int Med Res 2020;48:300060520904857. [PMID: 32090649 DOI: 10.1177/0300060520904857] [Reference Citation Analysis]
183 Buechter M, Kahraman A, Manka P, Gerken G, Dechêne A, Canbay A, Wetter A, Umutlu L, Theysohn JM. Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation. PLoS One 2017;12:e0177401. [PMID: 28494001 DOI: 10.1371/journal.pone.0177401] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
184 Lee TB, Yang K, Ko HJ, Shim JR, Choi BH, Lee JH, Ryu JH. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report. Medicine (Baltimore) 2021;100:e26463. [PMID: 34160449 DOI: 10.1097/MD.0000000000026463] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Spaander MCW, Van Buuren HR, Hansen BE, Janssen HLA. Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis: Ascites in patients with portal vein thrombosis. Alimentary Pharmacology & Therapeutics 2010;32:529-34. [DOI: 10.1111/j.1365-2036.2010.04375.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
186 Rössle M, Bettinger D, Trebicka J, Klinger C, Praktiknjo M, Sturm L, Caca K, Mücke VT, Radecke K, Engelmann C, Zipprich A, Heinzow H, Meyer C, Tappe U, Appenrodt B, Schmidt A, Lange C, Strassburg C, Zeuzem S, Grandt D, Schmidt H, Moessner J, Berg T, Lammert F, Thimme R, Schultheiß M. A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment. Aliment Pharmacol Ther 2020;52:329-39. [PMID: 32506456 DOI: 10.1111/apt.15811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
187 García Buey L, González Mateos F, Moreno-otero R. Cirrosis hepática. Medicine - Programa de Formación Médica Continuada Acreditado 2012;11:625-33. [DOI: 10.1016/s0304-5412(12)70359-1] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
188 Baladé Martínez L, Cabezuelo MM, Villamañan Bueno E, Rodríguez Martín E, Herrero Ambrosio A. Defibrotide for the treatment of severe hepatic sinusoidal obstruction syndrome: a single-centre experience. Eur J Hosp Pharm 2019;26:343-6. [PMID: 31798859 DOI: 10.1136/ejhpharm-2018-001575] [Reference Citation Analysis]
189 Abdel-aal AK, Ezzeldin IB, Hamed MF, Ibrahim RM, Berry M, Underwood ES, Saddekni S. Endovascular Treatment of Acute Portal Vein Thrombosis Using Ultrasound-Accelerated Catheter-Directed Thrombolysis. Vasc Endovascular Surg 2014;48:460-5. [DOI: 10.1177/1538574414547087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
190 Marzano C, Cazals-Hatem D, Rautou PE, Valla DC. The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome. Hepatology. 2015;62:956-963. [PMID: 25684451 DOI: 10.1002/hep.27747] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
191 Smalberg JH, Koehler E, Murad SD, Plessier A, Seijo S, Trebicka J, Primignani M, de Maat MPM, Garcia-pagan J, Valla DC, Janssen HLA, Leebeek FWG; for the European Network for Vascular Disorders of the Liver (EN-Vie). The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis. Blood 2011;117:3968-73. [DOI: 10.1182/blood-2010-11-319087] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
192 Deng L, Yin X, Zhao Y, Yang J, Yang H, Xu C, Li K. Outcomes of combination treatment with MARS and TIPS for hepatic veno-occlusive disease: a report of 12 cases. J Int Med Res 2020;48:300060520980877. [PMID: 33372815 DOI: 10.1177/0300060520980877] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Yang X, Lei P, Song Y, Fei Z, Ai Y, Shang H, Bai T, Ye J, Li X. Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome. Eur J Radiol 2021;138:109632. [PMID: 33711570 DOI: 10.1016/j.ejrad.2021.109632] [Reference Citation Analysis]
194 Sharma S, Kumar R, Rout G, Gamanagatti SR, Shalimar. Dabigatran as an oral anticoagulant in patients with Budd-Chiari syndrome post-percutaneous endovascular intervention. J Gastroenterol Hepatol 2020;35:654-62. [PMID: 31476024 DOI: 10.1111/jgh.14843] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
195 Al-Saleh S, John PR, Letarte M, Faughnan ME, Belik J, Ratjen F. Symptomatic liver involvement in neonatal hereditary hemorrhagic telangiectasia. Pediatrics 2011;127:e1615-20. [PMID: 21536610 DOI: 10.1542/peds.2010-2366] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
196 Kojima S, Watanabe N, Koizumi J, Kokubu S, Murashima N, Matsutani S, Obara K. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension: Current status of portal vein thrombosis in Japan. Hepatol Res 2018;48:244-54. [DOI: 10.1111/hepr.12983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
197 Pelizzo G, Quaretti P, Moramarco LP, Corti R, Maestri M, Iacob G, Calcaterra V. One step minilaparotomy-assisted transmesenteric portal vein recanalization combined with transjugular intrahepatic portosystemic shunt placement: A novel surgical proposal in pediatrics. World J Gastroenterol 2017; 23(15): 2811-2818 [PMID: 28487619 DOI: 10.3748/wjg.v23.i15.2811] [Cited by in CrossRef: 2] [Article Influence: 0.5] [Reference Citation Analysis]
198 Frankl J, Hennemeyer C, Flores MS, Desai AP. Budd-Chiari Syndrome in a Patient with Hepatitis C. Case Reports Hepatol 2016;2016:7493970. [PMID: 27525135 DOI: 10.1155/2016/7493970] [Reference Citation Analysis]
199 Nicoară-Farcău O, Rusu I, Stefănescu H, Tanțău M, Badea RI, Procopeț B. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World J Gastroenterol 2020; 26(22): 3000-3011 [PMID: 32587444 DOI: 10.3748/wjg.v26.i22.3000] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
200 Meng X, Lv Y, Zhang B, He C, Guo W, Luo B, Yin Z, Fan D, Han G. Endovascular Management of Budd-Chiari Syndrome with Inferior Vena Cava Thrombosis: A 14-Year Single-Center Retrospective Report of 55 Patients. J Vasc Interv Radiol 2016;27:1592-603. [PMID: 27397618 DOI: 10.1016/j.jvir.2016.04.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
201 Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, Xu H, Mancuso A, Zhang W, Han X. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment Pharmacol Ther. 2016;44:1152-1167. [PMID: 27734511 DOI: 10.1111/apt.13815] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 8.2] [Reference Citation Analysis]
202 Cheng Q, Tree K. Systematic Review of Thrombolysis Therapy in the Management of Non-Cirrhosis-Related Portal Vein Thrombosis. J Gastrointest Surg 2021;25:1579-90. [PMID: 33452971 DOI: 10.1007/s11605-020-04624-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Björck M, Koelemay M, Acosta S, Bastos Goncalves F, Kölbel T, Kolkman JJ, Lees T, Lefevre JH, Menyhei G, Oderich G, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Kakkos S, Koncar I, Sanddal Lindholt J, Vega de Ceniga M, Vermassen F, Verzini F, Document Reviewers, Geelkerken B, Gloviczki P, Huber T, Naylor R. Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017;53:460-510. [PMID: 28359440 DOI: 10.1016/j.ejvs.2017.01.010] [Cited by in Crossref: 190] [Cited by in F6Publishing: 140] [Article Influence: 63.3] [Reference Citation Analysis]
204 Du L, Zhu S, Lu Z, Xu T, Bai T, Xu D, Wei X, Li J, Xu K, Ye J, Hou X, Song Y. Ascitic cholesterol is superior to serum-ascites albumin gradient in the detection of non-portal hypertensive ascites and the diagnosis of mixed ascites. Aliment Pharmacol Ther 2019;49:91-8. [PMID: 30443960 DOI: 10.1111/apt.15042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
205 Young K, Wong R. Evaluation and management of acute and chronic portal vein thrombosis in patients with cirrhosis. Clin Liver Dis (Hoboken) 2017;10:152-6. [PMID: 30992777 DOI: 10.1002/cld.679] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
206 Abdel Hameed MR, Elbeih EAS, Abd El-Aziz HM, Afifi OA, Khalaf LMR, Ali Abu Rahma MZ, Sabry A. Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt. J Blood Med 2020;11:515-24. [PMID: 33408545 DOI: 10.2147/JBM.S278678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Rosenblatt R, Brown RS. Nonviral or Drug-Induced Etiologies of Acute Liver Failure. Clinics in Liver Disease 2018;22:347-60. [DOI: 10.1016/j.cld.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
208 Wallhult E, Quinn B. Early and Acute Complications and the Principles of HSCT Nursing Care. In: Kenyon M, Babic A, editors. The European Blood and Marrow Transplantation Textbook for Nurses. Cham: Springer International Publishing; 2018. pp. 163-95. [DOI: 10.1007/978-3-319-50026-3_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
209 Arai M, Kim S, Ishii H, Hagiwara J, Takiguchi T, Ishiki Y, Yokota H. Delayed development of portal vein thrombosis in a patient initially detected with portal venous gas and pneumatosis intestinalis: a case report. Acute Med Surg 2019;6:419-22. [PMID: 31592325 DOI: 10.1002/ams2.448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
210 Sofia C, Cattafi A, Silipigni S, Pitrone P, Carerj ML, Marino MA, Pitrone A, Ascenti G. Portal vein thrombosis in patients with chronic liver diseases: From conventional to quantitative imaging. Eur J Radiol 2021;142:109859. [PMID: 34284232 DOI: 10.1016/j.ejrad.2021.109859] [Reference Citation Analysis]
211 Das CJ, Soneja M, Tayal S, Chahal A, Srivastava S, Kumar A, Baruah U. Role of radiological imaging and interventions in management of Budd-Chiari syndrome. Clin Radiol 2018;73:610-24. [PMID: 29549997 DOI: 10.1016/j.crad.2018.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
212 Ke Z, Hao X, Ning W, Zu MH, Fun YF. Fibrinolysis status in the Budd-Chiari syndrome in China. Blood Coagul Fibrinolysis 2015;26:721-6. [PMID: 24911452 DOI: 10.1097/MBC.0000000000000143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
213 Singh G, Adhami T, Alkhouri N. Hereditary Hemorrhagic Telangiectasia With Liver Vascular Malformation Presenting With High-Output Heart Failure. ACG Case Rep J 2014;2:16-7. [PMID: 26157893 DOI: 10.14309/crj.2014.70] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
214 Hong EK, Joo I, Park J, Lee K. Assessment of hepatic sinusoidal obstruction syndrome with intravoxel incoherent motion diffusion-weighted imaging: An experimental study in a rat model. J MagnReson Imaging. 2020;51:81-89. [PMID: 31094055 DOI: 10.1002/jmri.26790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
215 Pahari H, Chaudhary RJ, Thiagarajan S, Raut V, Babu R, Bhangui P, Goja S, Rastogi A, Vohra V, Soin AS. Hepatic Venous and Inferior Vena Cava Morphology No Longer a Barrier to Living Donor Liver Transplantation for Budd-Chiari Syndrome: Surgical Techniques and Outcomes. Transplant Proc. 2016;48:2732-2737. [PMID: 27788809 DOI: 10.1016/j.transproceed.2016.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
216 Chen H, Lei J, Liang S, Luo G, Deng M, Lü M. Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis. Can J Gastroenterol Hepatol 2021;2021:8859602. [PMID: 34007837 DOI: 10.1155/2021/8859602] [Reference Citation Analysis]
217 Messaoudi Y, Hedfi M, Benhalima N, Chouchene A. Acute portal vein thrombosis secondary to hyperhomocysteinemia with folic acid deficiency and methyl tetrahydrofolate reductase mutation: a case report and literature review. Arch Med Sci Atheroscler Dis 2016;1:e1-5. [PMID: 28905011 DOI: 10.5114/amsad.2016.59575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
218 He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. World J Gastroenterol 2015; 21(8): 2413-2418 [PMID: 25741149 DOI: 10.3748/wjg.v21.i8.2413] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
219 Zhao Y, Ping J, Yu X, Cui Y, Yin J, Sun C, Hua G, Wang C, Li X, Tang L. Computational fluid dynamics simulation of time-resolved blood flow in Budd-Chiari syndrome with inferior vena cava stenosis and its implication for postoperative efficacy assessment. Clin Biomech (Bristol, Avon) 2021;82:105256. [PMID: 33508562 DOI: 10.1016/j.clinbiomech.2020.105256] [Reference Citation Analysis]
220 Valeriani E, Di Nisio M, Riva N, Cohen O, Garcia-Pagan JC, Magaz M, Porreca E, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis. Blood 2021;137:1233-40. [PMID: 32911539 DOI: 10.1182/blood.2020006827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
221 Ai MH, Dong WG, Tan XP, Xu L, Xu C, Zhang Q, Zhang Y, Li J. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:1395-400. [PMID: 32675774 DOI: 10.1097/MEG.0000000000001846] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
222 Jain R, Gupta K, Bhatia A, Bansal A, Bansal D. Hepatic Sinusoidal-obstruction Syndrome and Busulfan-induced Lung Injury in a Post-autologous Stem Cell Transplant Recipient. Indian Pediatr 2017;54:765-70. [PMID: 28984258 DOI: 10.1007/s13312-017-1172-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
223 Lyu J, Yang G, Mei Y, Guo L, Guo Y, Zhang X, Xu Y, Feng Y. Non-Gaussian Diffusion Models and T1 rho Quantification in the Assessment of Hepatic Sinusoidal Obstruction Syndrome in Rats. J Magn Reson Imaging 2020;52:1110-21. [PMID: 32246796 DOI: 10.1002/jmri.27156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
224 Zaman S, Wiebe S, Bernal W, Wendon J, Czuprynska J, Auzinger G. Increased prevalence of heparin-induced thrombocytopenia in patients with Budd-Chiari syndrome: a retrospective analysis. Eur J Gastroenterol Hepatol. 2016;28:967-971. [PMID: 27015137 DOI: 10.1097/meg.0000000000000632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
225 彭俏, 贺德志, 李建生. 肝小静脉闭塞病的临床现状及研究进展. 世界华人消化杂志 2012; 20(12): 1030-1035 [DOI: 10.11569/wcjd.v20.i12.1030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
226 Mancuso A. Management of Budd-Chiari syndrome in children: same debated issues as in adults. Eur J Gastroenterol Hepatol 2015;27:107-8. [PMID: 25426986 DOI: 10.1097/MEG.0000000000000232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
227 Xu ZG, Tang L, Zhao YB, Gao MF, Yang SM. Catheter-directed thrombolysis combined with anticoagulation for acute extensive portal vein thrombosis: Our experience: Catheter-directed thrombolysis for PVT. J Dig Dis 2018;19:635-40. [DOI: 10.1111/1751-2980.12649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
228 Cui S, Fu Z, Feng Y, Xie X, Ma X, Liu T, Wang L, Wu H, Zhu Q. The disseminated intravascular coagulation score is a novel predictor for portal vein thrombosis in cirrhotic patients with hepatitis B. Thromb Res 2018;161:7-11. [PMID: 29178991 DOI: 10.1016/j.thromres.2017.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
229 Kitajima K, Yoshikawa T, Seo Y, Ohno Y, Yano Y, Miki A, Kanda T, Kanata N, Azuma T, Sugimura K. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings. Magn Reson Imaging. 2011;29:579-583. [PMID: 21216550 DOI: 10.1016/j.mri.2010.10.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
230 Mancuso A. Budd-Chiari syndrome management: Lights and shadows. World J Hepatology 2011; 3(10): 262-264 [PMID: 22059108 DOI: 10.4254/wjh.v3.i10.262] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
231 Liew A, Douketis J. Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? Intern Emerg Med 2016;11:1037-40. [PMID: 27216797 DOI: 10.1007/s11739-016-1463-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
232 Kim PH, Gwon DI, Ko HK. Portal Vein Thrombosis after Endovascular Embolization of Splenic Artery for a Symptomatic Arterioportal Fistula: A Case Report and Literature Review. Annals of Vascular Surgery 2018;53:270.e7-270.e12. [DOI: 10.1016/j.avsg.2018.05.075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
233 Bedossa P, Hytiroglou P, Yeh MM. Vascular Disorders. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 636-72. [DOI: 10.1016/b978-0-7020-6697-9.00011-x] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
234 Wang Q, Han G. Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future. Abdom Radiol 2018;43:1908-19. [DOI: 10.1007/s00261-017-1341-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
235 Licinio R, Principi M, Losurdo G, Ierardi E, Di Leo A. Letter: portal vein obstruction--which subset of patients could benefit the most? Aliment Pharmacol Ther 2015;41:909. [PMID: 25846387 DOI: 10.1111/apt.13130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
236 Qi X, Ren W, De Stefano V, Fan D. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:1801-12.e7. [PMID: 24793031 DOI: 10.1016/j.cgh.2014.04.026] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 8.7] [Reference Citation Analysis]
237 Huard G, Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol. 2012;2012:672986. [PMID: 22778970 DOI: 10.1155/2012/672986] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
238 Yang XQ, Ye J, Li X, Li Q, Song YH. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol 2019; 25(28): 3753-3763 [PMID: 31391770 DOI: 10.3748/wjg.v25.i28.3753] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
239 Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, Bai M, Meng X, Niu J, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54:78-88. [PMID: 20932597 DOI: 10.1016/j.jhep.2010.06.029] [Cited by in Crossref: 144] [Cited by in F6Publishing: 128] [Article Influence: 13.1] [Reference Citation Analysis]
240 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis. 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
241 Riva N, Ageno W. Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's Perspective. J Transl Int Med 2018;6:6-10. [PMID: 29607297 DOI: 10.2478/jtim-2018-0002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
242 Wu K, Ye C, Lin L, Chu Y, Ji M, Dai W, Zeng X, Lin Y. Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT. Clin Sci (Lond) 2016;130:1469-80. [PMID: 27226339 DOI: 10.1042/CS20160334] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
243 van den Broek MA, Vreuls CP, Winstanley A, Jansen RL, van Bijnen AA, Dello SA, Bemelmans MH, Dejong CH, Driessen A, Olde Damink SW. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases. Ann Surg Oncol 2013;20:1462-9. [PMID: 23463086 DOI: 10.1245/s10434-013-2915-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
244 Raja K, Jacob M, Asthana S. Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol 2014;4:320-31. [PMID: 25755579 DOI: 10.1016/j.jceh.2013.12.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
245 Zhou H, Wang YX, Lou HY, Xu XJ, Zhang MM. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol. 2014;15:218-225. [PMID: 24643319 DOI: 10.3348/kjr.2014.15.2.218] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
246 Stempak-Droissart T, Rousset-Jablonski C, Spritzer PM, Lalhou N, Larger E, Pichard C, Plessier A, Gompel A. Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women. Clin Res Hepatol Gastroenterol 2021;:101756. [PMID: 34303004 DOI: 10.1016/j.clinre.2021.101756] [Reference Citation Analysis]
247 Zhu S, Du L, Xu D, Lu Z, Xu T, Li J, Xu K, Ye J, Song Y. Ascitic fluid total protein, a useful marker in non-portal hypertensive ascites. J Gastroenterol Hepatol 2020;35:271-7. [PMID: 31247673 DOI: 10.1111/jgh.14768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
248 Dolai TK, Nataraj KS, Bhattacharya M, Ghosh MK. Veno-occlusive disease following high dose melphalan. Indian J Hematol Blood Transfus 2012;28:62-3. [PMID: 23449090 DOI: 10.1007/s12288-011-0100-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
249 Qi X, Wu F, He C, Fan D, Han G. Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature. European Journal of Gastroenterology & Hepatology 2015;27:77-83. [DOI: 10.1097/meg.0000000000000221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
250 Schultheiß M, Bettinger D, Thimme R, Rössle M. 30 Jahre transjugulärer intrahepatischer portosystemischer Shunt (TIPS) – Rückblick und Perspektive. Z Gastroenterol 2020;58:877-89. [DOI: 10.1055/a-1217-7866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Marsicano E, Vuong GM, Prather CM. Gastrointestinal causes of abdominal pain. Obstet Gynecol Clin North Am 2014;41:465-89. [PMID: 25155126 DOI: 10.1016/j.ogc.2014.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
252 Kola SM, Kumar P, Choonara YE, du Toit LC, Pillay V. Hypothesis: Can drug-loaded platelets be used as delivery vehicles for blood-brain barrier penetration? Med Hypotheses 2019;125:75-8. [PMID: 30902155 DOI: 10.1016/j.mehy.2019.02.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
253 Loudin M, Ahn J. Portal Vein Thrombosis in Cirrhosis. J Clin Gastroenterol. 2017;51:579-585. [PMID: 28489645 DOI: 10.1097/mcg.0000000000000834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
254 MacNicholas R, Olliff S, Elias E, Tripathi D. An update on the diagnosis and management of Budd-Chiari syndrome. Expert Rev Gastroenterol Hepatol. 2012;6:731-744. [PMID: 23237258 DOI: 10.1586/egh.12.56] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
255 Puccia F, Lombardo V, Giannitrapani L, Licata A, Mazzola G, Soresi M. Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult. J Ultrasound. 2017;20:161-165. [PMID: 28593007 DOI: 10.1007/s40477-016-0227-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
256 Gaballa D, Bezinover D, Kadry Z, Eyster E, Wang M, Northup PG, Stine JG. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index. Liver Transpl 2019;25:1747-55. [PMID: 31436367 DOI: 10.1002/lt.25630] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
257 Boskovic A, Kitic I, Stankovic I, Prokic D, Zlatar N. Primary Budd–Chiari syndrome in a 3-year-old boy with homozygous factor V Leiden G1691A mutation. Eur J Pediatr 2014;173:393-5. [DOI: 10.1007/s00431-013-2031-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
258 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
259 Bureau C, Laurent J, Robic MA, Christol C, Guillaume M, Ruidavets JB, Ferrieres J, Péron JM, Vinel JP. Central obesity is associated with non-cirrhotic portal vein thrombosis. Journal of Hepatology 2016;64:427-32. [DOI: 10.1016/j.jhep.2015.08.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
260 Rubbia-Brandt L. [Hepatic lesions induced by systemic chemotherapy for digestive cancer]. Ann Pathol 2010;30:421-5. [PMID: 21167427 DOI: 10.1016/j.annpat.2010.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
261 Shalimar, Sharma S, Gamanagatti SR, Chauhan A, Vuyyuru SK, Elhence A, Rout G, Saraya A, Gunjan D, Nayak B, Kumar R, Acharya SK. Acute-on-Chronic Liver Failure in Budd–Chiari Syndrome: Profile and Predictors of Outcome. Dig Dis Sci 2020;65:2719-29. [DOI: 10.1007/s10620-019-06005-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
262 Rajesh S, Mukund A, Arora A. Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterol Res Pract 2015;2015:101029. [PMID: 26600801 DOI: 10.1155/2015/101029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
263 Costache RS, Dragomirică AS, Dumitraș EA, Mariana J, Căruntu A, Popescu A, Costache DO. Portal vein thrombosis: A concise review (Review). Exp Ther Med 2021;22:759. [PMID: 34035856 DOI: 10.3892/etm.2021.10191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Magaz M, Alvarez-Larrán A, Colomer D, López-Guerra M, García-Criado MÁ, Mezzano G, Belmonte E, Olivas P, Soy G, Cervantes F, Darnell A, Ferrusquía-Acosta J, Baiges A, Turon F, Hernández-Gea V, García-Pagán JC. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis. J Hepatol 2021;74:89-95. [PMID: 32679300 DOI: 10.1016/j.jhep.2020.06.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
265 Botti S, Orlando L, Gargiulo G, Cecco VD, Banfi M, Duranti L, Samarani E, Netti MG, Deiana M, Galuppini V, Pignatelli AC, Ceresoli R, Vedovetto A, Rostagno E, Bambaci M, Dellaversana C, Luminari S, Bonifazi F. Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group. Ecancermedicalscience 2016;10:661. [PMID: 27594906 DOI: 10.3332/ecancer.2016.661] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
266 Barbui T, De Stefano V. Management of venous thromboembolism in myeloproliferative neoplasms. Curr Opin Hematol 2017;24:108-14. [PMID: 27875375 DOI: 10.1097/MOH.0000000000000312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
267 Gioia S, Nardelli S, Ridola L, d’Amati G, Riggio O. Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis? World J Hepatol 2019; 11(8): 613-618 [PMID: 31528244 DOI: 10.4254/wjh.v11.i8.613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
268 Yang S, He C, Fan X, Ding W, Wu X, Li J. Early Prophylactic Anticoagulation via Transjugular Intrahepatic Route for Portal Vein Thrombosis after Splenectomy in Cirrhotic Portal Hypertension. Journal of Vascular and Interventional Radiology 2015;26:1009-17. [DOI: 10.1016/j.jvir.2015.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
269 Qi X, De Stefano V, Su C, Bai M, Guo X, Fan D. Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis. Medicine (Baltimore) 2015;94:e496. [PMID: 25634200 DOI: 10.1097/MD.0000000000000496] [Cited by in Crossref: 33] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
270 Ageno W. Managing unusual presentations of venous thromboembolism. J Thromb Thrombolysis 2015;39:304-10. [DOI: 10.1007/s11239-015-1171-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
271 Fan JG, Wang FS. Reply: To PMID 19399912. Hepatology 2015;62:657. [PMID: 25476406 DOI: 10.1002/hep.27627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
272 Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: When to treat and how? Vasc Med. 2016;21:61-69. [PMID: 26584887 DOI: 10.1177/1358863x15611224] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
273 Gao X, Gui E, Lu Z, Ning X, Zu M, Zhang P, Sun G. Risk factors of recurrence among 471 Chinese patients with Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2015;39:620-626. [PMID: 25656980 DOI: 10.1016/j.clinre.2014.12.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
274 Hidaka H, Kokubu S, Sato T, Katsushima S, Izumi N, Igura T, Asahara S, Notsumata K, Osaki Y, Tsuji K, Kawanaka H, Akahoshi T, Hirota S, Matsutani S; NPB-06 study group. Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial. Hepatol Res 2018;48:E107-16. [PMID: 28666312 DOI: 10.1111/hepr.12934] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
275 Sonzogni A, Previtali G, Seghezzi M, Grazia Alessio M, Gianatti A, Licini L, Morotti D, Zerbi P, Carsana L, Rossi R, Lauri E, Pellegrinelli A, Nebuloni M. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations. Liver Int. 2020;40:2110-2116. [PMID: 32654359 DOI: 10.1111/liv.14601] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 62.0] [Reference Citation Analysis]
276 Ishikawa M, Sakamoto A. Open Cardiac Surgery in a Patient With Chronic Budd-Chiari Syndrome. J Cardiothorac Vasc Anesth 2021;35:3042-4. [PMID: 33358289 DOI: 10.1053/j.jvca.2020.11.063] [Reference Citation Analysis]
277 Orloff MJ, Isenberg JI, Wheeler HO, Daily PO, Girard B. Budd–Chiari Syndrome Revisited: 38 Years’ Experience with Surgical Portal Decompression. J Gastrointest Surg 2012;16:286-300. [DOI: 10.1007/s11605-011-1738-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
278 Qi XS, Ren WR, Fan DM, Han GH. Selection of treatment modalities for Budd-Chiari Syndrome in China: A preliminary survey of published literature. World J Gastroenterol 2014; 20(30): 10628-10636 [PMID: 25132785 DOI: 10.3748/wjg.v20.i30.10628] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
279 Qi X, Han G, He C, Yin Z, Guo W, Niu J, Fan D. CT features of non-malignant portal vein thrombosis: a pictorial review. Clin Res Hepatol Gastroenterol. 2012;36:561-568. [PMID: 22883835 DOI: 10.1016/j.clinre.2012.05.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
280 Naymagon L. Venous thrombosis of the liver: current and emerging concepts in management. Transl Res 2020;225:54-69. [PMID: 32407789 DOI: 10.1016/j.trsl.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
281 Rautou PE. Budd-Chiari syndrome. Clin Liver Dis (Hoboken) 2014;3:133-6. [PMID: 30992907 DOI: 10.1002/cld.366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
282 Senzolo M, Riggio O, Primignani M; Italian Association for the Study of the Liver (AISF) ad hoc. Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. Dig Liver Dis. 2011;43:503-514. [PMID: 21185794 DOI: 10.1016/j.dld.2010.11.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
283 A Sakr M, Abdelhakam SM, Dabbous HM, Abdelmoaty AS, Ebada HE, Al-Banna WM, Ghazy MS, Aboelmaaty ME, Eldorry AK. Pattern of Vascular Involvement in Egyptian Patients with Budd-Chiari Syndrome: Relation to Etiology and Impact on Clinical Presentation. Ann Hepatol 2018;17:638-44. [PMID: 29893705 DOI: 10.5604/01.3001.0012.0933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
284 Qi X, Han G, Yin Z, He C, Bai M, Yang Z, Guo W, Niu J, Wu K, Fan D. A large portal vein: a rare finding of recent portal vein thrombosis. Case Rep Gastroenterol 2011;5:33-9. [PMID: 21326856 DOI: 10.1159/000323386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
285 Seijo S, Garcia-pagan JC. An overview of current treatment methods for Budd–Chiari syndrome. Expert Opinion on Orphan Drugs 2014;2:147-57. [DOI: 10.1517/21678707.2014.872560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
286 Cool J, Rosenblatt R, Kumar S, Lucero C, Fortune B, Crawford C, Jesudian A. Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort. Journal of Gastroenterology and Hepatology 2018;34:1088-92. [DOI: 10.1111/jgh.14501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
287 Chan SS, Colecchia A, Duarte RF, Bonifazi F, Ravaioli F, Bourhis JH. Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biol Blood Marrow Transplant 2020;26:1770-9. [PMID: 32593647 DOI: 10.1016/j.bbmt.2020.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
288 Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Adv Ther 2021;38:495-520. [PMID: 33155180 DOI: 10.1007/s12325-020-01550-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
289 Elsayes KM, Shaaban AM, Rothan SM, Javadi S, Madrazo BL, Castillo RP, Casillas VJ, Menias CO. A Comprehensive Approach to Hepatic Vascular Disease. RadioGraphics 2017;37:813-36. [DOI: 10.1148/rg.2017160161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
290 Working Subgroup for Clinical Practice Guideline for Aberrant Portal Hemodynamics*,**. Diagnosis and treatment guidelines for aberrant portal hemodynamics: The Aberrant Portal Hemodynamics Study Group supported by the Ministry of Health, Labor and Welfare of Japan. Hepatol Res. 2017;47:373-386. [PMID: 28058764 DOI: 10.1111/hepr.12862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
291 Sekhar M, McVinnie K, Burroughs AK. Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol 2013;162:730-47. [PMID: 23855810 DOI: 10.1111/bjh.12461] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
292 Kmeid M, Liu X, Ballentine S, Lee H. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data. Gastroenterology Res 2021;14:49-65. [PMID: 34007347 DOI: 10.14740/gr1376] [Reference Citation Analysis]
293 Shalimar, Gamanagatti SR, Patel AH, Kedia S, Nayak B, Gunjan D, Ranjan G, Paul SB, Acharya SK. Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome. Eur J Gastroenterol Hepatol. 2017;29:1174-1182. [PMID: 28763339 DOI: 10.1097/meg.0000000000000945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
294 Odah T, Al-Khazraji A, Idriss R, Morrow M, Curry MP. Budd-Chiari Syndrome in a Patient With Simultaneous Diagnosis of Hepatic Sarcoidosis and Nodular Regenerative Hyperplasia. ACG Case Rep J 2019;6:e00200. [PMID: 31750374 DOI: 10.14309/crj.0000000000000200] [Reference Citation Analysis]
295 Ageno W, Beyer-Westendorf J, Garcia DA, Lazo-Langner A, McBane RD, Paciaroni M. Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis 2016;41:129-43. [PMID: 26780742 DOI: 10.1007/s11239-015-1308-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 9.4] [Reference Citation Analysis]
296 Mancuso A. An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment. Eur J Gastroenterol Hepatol 2015;27:200-3. [PMID: 25590783 DOI: 10.1097/MEG.0000000000000282] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
297 Galloula A, Rossi A, Gautier V, Minozzi C, Messas E, Mirault T. Thrombose portale associée à une infection aiguë à cytomégalovirus. Journal des Maladies Vasculaires 2014;39:224-30. [DOI: 10.1016/j.jmv.2014.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
298 Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J, Shan H. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. J Vasc Interv Radiol. 2013;24:1808-1816. [PMID: 24099787 DOI: 10.1016/j.jvir.2013.08.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
299 Plompen EP, Schouten JN, Janssen HL. Role of anticoagulant therapy in liver disease. Hepatol Int. 2013;7:369-376. [PMID: 26201771 DOI: 10.1007/s12072-013-9427-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
300 Zhu L, Zhang CY, Li DP, Chen HB, Ma J, Gao H, Ye Y, Wang JY, Fu PP, Lin G. Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China. Acta Pharmacol Sin 2021;42:1212-22. [PMID: 33154553 DOI: 10.1038/s41401-020-00553-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
301 Erlinger S. Hereditary haemorrhagic telangiectasia. Gastroenterol Clin Biol 2010;34:475-6. [PMID: 20576378 DOI: 10.1016/j.gcb.2010.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
302 Mancuso A. Management of portal vein thrombosis in cirrhosis: an update. Eur J Gastroenterol Hepatol. 2016;28:739-743. [PMID: 27075588 DOI: 10.1097/meg.0000000000000633] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
303 Edgar JA, Molyneux RJ, Colegate SM. Pyrrolizidine Alkaloids: Potential Role in the Etiology of Cancers, Pulmonary Hypertension, Congenital Anomalies, and Liver Disease. Chem Res Toxicol 2015;28:4-20. [PMID: 25483859 DOI: 10.1021/tx500403t] [Cited by in Crossref: 110] [Cited by in F6Publishing: 101] [Article Influence: 15.7] [Reference Citation Analysis]
304 Ye QB, Huang QF, Luo YC, Wen YL, Chen ZK, Wei AL. Budd-Chiari syndrome associated with liver cirrhosis: A case report. World J Clin Cases 2021; 9(12): 2937-2943 [PMID: 33969080 DOI: 10.12998/wjcc.v9.i12.2937] [Reference Citation Analysis]
305 Khoury T, Massarwa M, Hazou W, Daher S, Hakimian D, Benson AA, Ashqar T, Mahamid M, Yaari S. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. J Gastrointest Cancer 2019;50:759-62. [PMID: 30043228 DOI: 10.1007/s12029-018-0149-5] [Reference Citation Analysis]
306 Martinez M, Tandra A, Vuppalanchi R. Treatment of acute portal vein thrombosis by nontraditional anticoagulation. Hepatology. 2014;60:425-426. [PMID: 24395623 DOI: 10.1002/hep.26998] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
307 Mancuso A. Cirrhosis development probably arises from chronic micro-vascular ischemia. Med Hypotheses 2014;82:244. [PMID: 24389105 DOI: 10.1016/j.mehy.2013.11.044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
308 Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol. 2013;48:771-784. [PMID: 23506234 DOI: 10.3109/00365521.2013.777775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
309 Weisberg IS, Jacobson IM. Cardiovascular diseases and the liver. Clin Liver Dis 2011;15:1-20. [PMID: 21111990 DOI: 10.1016/j.cld.2010.09.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
310 Mancuso A. The ischemic liver cirrhosis theory and its clinical implications. Med Hypotheses 2016;94:4-6. [PMID: 27515188 DOI: 10.1016/j.mehy.2016.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
311 He F, Zhao H, Dai S, Wu Y, Wang L, Huang H, Yue Z, Fan Z, Dong X, Liu F. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep. 2016;6:36380. [PMID: 27805025 DOI: 10.1038/srep36380] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
312 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
313 Strauss E, Valla D. Non-cirrhotic portal hypertension--concept, diagnosis and clinical management. Clin Res Hepatol Gastroenterol 2014;38:564-9. [PMID: 24581591 DOI: 10.1016/j.clinre.2013.12.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
314 Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int. 2012;6:576-590. [PMID: 26201472 DOI: 10.1007/s12072-011-9324-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
315 Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci 2016;12:1381-3. [PMID: 27904533 DOI: 10.5114/aoms.2016.62921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
316 Serag WM, Mohammed BSE, Mohamed MM, Elsayed BE. Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma. Heliyon 2020;6:e04677. [PMID: 32904199 DOI: 10.1016/j.heliyon.2020.e04677] [Reference Citation Analysis]
317 Tremblay D, Naymagon L, Troy K, Cromwell C, Edwards C, Schiano T, Kremyanskaya M, Mascarenhas J. The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis. Blood Coagul Fibrinolysis 2020;31:213-8. [PMID: 32101880 DOI: 10.1097/MBC.0000000000000901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
318 Giouleme O, Theocharidou E. Management of Portal Hypertension in Children With Portal Vein Thrombosis. Journal of Pediatric Gastroenterology & Nutrition 2013;57:419-25. [DOI: 10.1097/mpg.0b013e3182a1cd7f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
319 Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology 2013;58:2142-52. [PMID: 23775835 DOI: 10.1002/hep.26578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
320 Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM. Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr 2017;64:639-52. [PMID: 27984347 DOI: 10.1097/MPG.0000000000001492] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
321 Stine JG, Wang J, Shah PM, Argo CK, Intagliata N, Uflacker A, Caldwell SH, Northup PG. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study. Liver Int. 2018;38:94-101. [PMID: 28632958 DOI: 10.1111/liv.13500] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
322 Qi X, He C, Yin Z, Wang Z, Zhang H, Yao L, Wang J, Xia J, Cai H, Yang Z, Bai M, Guo W, Niu J, Wu K, Fan D, Han G; PVT-TIPS Study Group. Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open 2013;3:e003370. [PMID: 23847271 DOI: 10.1136/bmjopen-2013-003370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
323 Qi X, Fan D, Han G. Timing of transjugular intrahepatic portosystmic for Budd-Chiari syndrome: still an open issue. Liver Int 2014;34:1288-9. [PMID: 24684318 DOI: 10.1111/liv.12554] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
324 Chen C. Direct thrombolytic therapy in portal and mesenteric vein thrombosis. Journal of Vascular Surgery 2012;56:1124-6. [DOI: 10.1016/j.jvs.2012.04.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
325 Seijo S, García-criado Á, Darnell A, García-pagán JC. Diagnóstico y tratamiento de la trombosis portal en la cirrosis hepática. Gastroenterología y Hepatología 2012;35:660-6. [DOI: 10.1016/j.gastrohep.2012.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
326 Smith AA, Nelson M. High-Output Heart Failure from a Hepatic Hemangioma With Exertion-Induced Hypoxia. Am J Cardiol. 2016;117:157-158. [PMID: 26525213 DOI: 10.1016/j.amjcard.2015.10.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
327 Pang P, Hu X, Zhou B, Mao J, Liang Y, Jiang Z, Huang M, Liu R, Zhang Y, Qian J, Liu J, Xu J, Zhang Y, Zu M, Wang Y, He H, Shan H. DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera. Hepatology 2019;69:803-16. [PMID: 30063812 DOI: 10.1002/hep.30200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
328 Stolz DB. Sinusoidal Endothelial Cells. In: Monga SPS, editor. Molecular Pathology of Liver Diseases. Boston: Springer US; 2011. pp. 97-107. [DOI: 10.1007/978-1-4419-7107-4_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
329 Gao Y, Liu H, Tang F, Zhang X, Li F, Ye Q, Yuan H, Lv H, Han T. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis. Clin Res Hepatol Gastroenterol 2021;45:101649. [PMID: 33601064 DOI: 10.1016/j.clinre.2021.101649] [Reference Citation Analysis]
330 Qi X, Han G, Fan D. The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt? Hepatology. 2010;51:713-714. [PMID: 20104582 DOI: 10.1002/hep.23217] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
331 Berry K, Taylor J, Liou IW, Ioannou GN. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13:585-593. [PMID: 25459555 DOI: 10.1016/j.cgh.2014.10.010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
332 Ilcewicz HN, Martello JL, Piechowski K. Evaluation of the efficacy and safety of direct oral anticoagulants in the treatment of portal vein thrombosis. Eur J Gastroenterol Hepatol 2021;33:911-6. [PMID: 33079786 DOI: 10.1097/MEG.0000000000001958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
333 He FL, Li C, Liu FQ, Qi XS. Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study. World J Clin Cases 2019; 7(2): 130-136 [PMID: 30705890 DOI: 10.12998/wjcc.v7.i2.130] [Reference Citation Analysis]
334 Khan F, Armstrong MJ, Mehrzad H, Chen F, Neil D, Brown R, Cain O, Tripathi D. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther. 2019;49:840-863. [PMID: 30828850 DOI: 10.1111/apt.15149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
335 Qi X, Han G, Bai M, Fan D. Stage of portal vein thrombosis. Journal of Hepatology 2011;54:1080-2. [DOI: 10.1016/j.jhep.2010.10.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
336 Rajani R, Björnsson E, Bergquist A, Danielsson A, Gustavsson A, Grip O, Melin T, Sangfelt P, Wallerstedt S, Almer S. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther. 2010;32:1154-1162. [PMID: 21039677 DOI: 10.1111/j.1365-2036.2010.04454.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 67] [Article Influence: 8.5] [Reference Citation Analysis]
337 Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921-4928. [PMID: 23043069 DOI: 10.1182/blood-2011-09-376517] [Cited by in Crossref: 194] [Cited by in F6Publishing: 151] [Article Influence: 21.6] [Reference Citation Analysis]
338 Lakhoo J, Gaba RC. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis. Diagn Interv Imaging. 2016;97:1085-1093. [PMID: 27481577 DOI: 10.1016/j.diii.2016.07.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
339 Hayashi T, Takatori H, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Kitamura K, Kawaguchi K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Toyama T, Okumura K, Kozaka K, Kaneko S. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients. BMC Gastroenterol 2019;19:217. [PMID: 31842768 DOI: 10.1186/s12876-019-1140-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
340 Qi X, He C, Han G, Yin Z, Wu F, Zhang Q, Niu J, Wu K, Fan D. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 2013;28:148-52. [PMID: 23020629 DOI: 10.1111/j.1440-1746.2012.07282.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
341 Qi X, De Stefano V, Wang J, Bai M, Yang Z, Han G, Fan D. Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol. 2013;28:432-442. [PMID: 23216127 DOI: 10.1111/jgh.12085] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
342 Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, Niu J, Bai M, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Liver Int. 2016;36:667-676. [PMID: 26235541 DOI: 10.1111/liv.12929] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
343 Tufano A, Ageno W, Di Micco P, Niglio A, Rosa V, Ballaz A, Braester A, Rubio CM, Isern V, Imbalzano E, Monreal M. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. Thrombosis Research 2018;164:69-74. [DOI: 10.1016/j.thromres.2018.02.143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
344 Alnajjar A, Al-Hussaini H, Al Sebayel M, Al-Kattan W, Elsiesy H. Liver Transplantation for Budd-Chiari Syndrome With Large Solitary Focal Nodular Hyperplasia of the Liver in a Patient With Essential Thrombocythemia: Case Report. [Corrected]. Transplant Proc 2015;47:2282-6. [PMID: 26361700 DOI: 10.1016/j.transproceed.2015.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
345 Cai X, Wu J, Gui R, Huang Q, Liu X, Qin Y, Wang J, Zeng Q, Jiang Q, Jiang H, Lu J, Wang J, Gao L, Zhang X, Zhang H, Feng J, Zhao X, Chang Y, Liu Y, Xu L, Liu K, Huang X, Zhang X. Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation. Ann Hematol 2019;98:1733-42. [DOI: 10.1007/s00277-019-03698-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
346 Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141-155. [PMID: 23363263 DOI: 10.1586/egh.12.83] [Cited by in Crossref: 144] [Cited by in F6Publishing: 106] [Article Influence: 18.0] [Reference Citation Analysis]
347 Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, Northup PG. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol 2015; 7(27): 2774-2780 [PMID: 26644821 DOI: 10.4254/wjh.v7.i27.2774] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 11.0] [Reference Citation Analysis]
348 Modaresi Esfeh J, Ansari-Gilani K. Transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol. 2020;32:762-763. [PMID: 32355095 DOI: 10.1097/meg.0000000000001680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Seksik P, Mary J, Beaugerie L, Lémann M, Colombel J, Vernier-massouille G, Cosnes J. Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine: . Inflammatory Bowel Diseases 2011;17:565-72. [DOI: 10.1002/ibd.21330] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
350 Lertpipopmetha K, Auewarakul CU. High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC Gastroenterol. 2011;11:66. [PMID: 21658275 DOI: 10.1186/1471-230x-11-66] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
351 Han G, Qi X, Zhang W, He C, Yin Z, Wang J, Xia J, Xu K, Guo W, Niu J, Wu K, Fan D. Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology. 2013;266:657-667. [PMID: 23143028 DOI: 10.1148/radiol.12120856] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
352 Afaa TJ, Amegan-Aho KH, Richardson E, Goka B. Diagnosis and management of extrahepatic oesophageal variceal bleed in children in a low resourced setting. Ghana Med J 2020;54:274-8. [PMID: 33883777 DOI: 10.4314/gmj.v54i4.11] [Reference Citation Analysis]
353 Benmassaoud A, Alrubaiy L, Yu D, Chowdary P, Sekhar M, Parikh P, Finkel J, See TC, O’beirne J, Leithead JA, Patch D. A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia. Aliment Pharmacol Ther 2019;50:1049-58. [DOI: 10.1111/apt.15479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
354 Liu F, Rong X, Guo H, Xu D, Liu C, Meng L, Yang X, Guo T, Kan X, Song Y. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterol 2020;20:30. [PMID: 32019495 DOI: 10.1186/s12876-020-1180-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
355 Zhang DQ, Mu YP, Xu Y, Chen JM, Liu P, Liu W. Research Progress in Chinese Medicine Preparations for Promoting Blood Circulation and Removing Blood Stasis for Cirrhotic Patients with Portal Vein Thrombosis Following Splenectomy. Chin J Integr Med 2020. [PMID: 32691285 DOI: 10.1007/s11655-020-3271-8] [Reference Citation Analysis]
356 Sun YL, Li WQ, Ding PX, Wang ZW, Wei CH, Ma XX, Zhang RF, Wu Y, Zhou L, Liang RP, Zhang YP, Zhao YP, Zhu RT, Li J. Specific alterations in gut microbiota are associated with prognosis of Budd-Chiari syndrome. Oncotarget 2018;9:3303-20. [PMID: 29423048 DOI: 10.18632/oncotarget.23234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
357 Massoure M, Ezanno A, Millot I, Fixot K, Rey P, Sockeel P. Thrombose aiguë de la veine porte associée à une primo-infection à cytomégalovirus chez un adulte immunocompétent et compliquée d’un syndrome du compartiment abdominal. Gastroentérologie Clinique et Biologique 2010;34:e3-5. [DOI: 10.1016/j.gcb.2010.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
358 Cast AE, Walter TJ, Huppert SS. Vascular patterning sets the stage for macro and micro hepatic architecture. Dev Dyn 2015;244:497-506. [PMID: 25370311 DOI: 10.1002/dvdy.24222] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
359 Loss M, Lang SA, Uller W, Wohlgemuth WA, Schlitt HJ. Combined Surgical and Interventional Therapy of Acute Portal Vein Thrombosis without Cirrhosis: A New Effective Hybrid Approach for Recanalization of the Portal Venous System. Journal of the American College of Surgeons 2014;218:e79-86. [DOI: 10.1016/j.jamcollsurg.2013.11.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
360 Rautou PE, Douarin L, Denninger MH, Escolano S, Lebrec D, Moreau R, Vidaud M, Itzykson R, Moucari R, Bezeaud A. Bleeding in patients with Budd-Chiari syndrome. J Hepatol. 2011;54:56-63. [PMID: 20889223 DOI: 10.1016/j.jhep.2010.06.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
361 Barbier CE, Rorsman F, Eriksson LG, Sangfelt P, Sheikhi R, Vessby J, Nyman R. Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions - a retrospective evaluation. Acta Radiol Open 2020;9:2058460120964074. [PMID: 33110628 DOI: 10.1177/2058460120964074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
362 Mancuso A. An update on management of Budd-Chiari syndrome. Annals of Hepatology 2014;13:323-6. [DOI: 10.1016/s1665-2681(19)30860-9] [Cited by in Crossref: 26] [Article Influence: 3.7] [Reference Citation Analysis]
363 Schreiner M, Barck T, Foroutan B, Baumgarten U. A rare cause of portal vein thrombosis in a previously healthy young man with acute hepatitis. J Clin Virol 2011;51:152-4. [PMID: 21493127 DOI: 10.1016/j.jcv.2011.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
364 Zhuge Y, Liu Y, Xie W, Zou X, Xu J, Wang J; Chinese Society of Gastroenterology Committee of Hepatobiliary Disease. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. J Gastroenterol Hepatol. 2019;34:634-642. [PMID: 30669184 DOI: 10.1111/jgh.14612] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
365 Wang X, Qi X, Guo X. Tusanqi-Related Sinusoidal Obstruction Syndrome in China: A Systematic Review of the Literatures. Medicine (Baltimore). 2015;94:e942. [PMID: 26061322 DOI: 10.1097/md.0000000000000942] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
366 Riggio O, Marzano C, Papa A, Pasquale C, Gasperini ML, Gigante A, Valla DC, Plessier A, Amoroso A. Small hepatic veins Budd-Chiari syndrome. J Thromb Thrombolysis 2014;37:536-9. [PMID: 23813023 DOI: 10.1007/s11239-013-0959-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
367 Gomes AC, Rubino G, Pinto C, Cipriano A, Furtado E, Gonçalves I. Budd-Chiari syndrome in children and outcome after liver transplant: Budd-Chiari Syndrome in children. Pediatric Transplantation 2012;16:E338-41. [DOI: 10.1111/j.1399-3046.2012.01683.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
368 Haris M, Thachil J. The problem with incidental and chronic portal vein thrombosis. European Journal of Internal Medicine 2017;39:e29-30. [DOI: 10.1016/j.ejim.2017.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
369 Campbell S, Lachlan NJ. Anticoagulation for Cirrhotic Portal Vein Thrombosis: Bold, Brave, and Possibly Beneficial. Clinical Gastroenterology and Hepatology 2012;10:784-5. [DOI: 10.1016/j.cgh.2012.03.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
370 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57:203-212. [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034] [Cited by in Crossref: 133] [Cited by in F6Publishing: 109] [Article Influence: 14.8] [Reference Citation Analysis]
371 Gianotti R, Charles H, Hymes K, Chandarana H, Sigal S. Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder. World J Gastroenterol 2014; 20(39): 14495-14499 [PMID: 25339837 DOI: 10.3748/wjg.v20.i39.14495] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
372 Kurtcehajic A, Zerem E, Hujdurovic A, Fejzic JA. Thrombotic risk factors in nonmalignant and noncirrhotic patients with portal vein thrombosis: need for extensive investigation. Eur J Gastroenterol Hepatol. 2016;28:116-118. [PMID: 26594916 DOI: 10.1097/MEG.0000000000000501] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
373 Sharma A, Keshava SN, Eapen A, Elias E, Eapen CE. An Update on the Management of Budd-Chiari Syndrome. Dig Dis Sci 2021;66:1780-90. [PMID: 32691382 DOI: 10.1007/s10620-020-06485-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
374 Wallhult E, Kenyon M, Liptrott S, Mank A, Ní Chonghaile M, Babic A, Bijkerk J, Bompoint C, Corbacioglu S, de Weijer R, Fink C, Marktel S, Soni V, Sprenger S, Arjona ET, Mohty M. Management of veno-occlusive disease: the multidisciplinary approach to care. Eur J Haematol 2017;98:322-9. [DOI: 10.1111/ejh.12840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
375 Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci 2017;3. [PMID: 30221012 DOI: 10.15761/JTS.1000182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
376 Robertson M, Hayes P. Management of portal hypertension, Budd–Chiari syndrome and portal vein thrombosis. Medicine 2015;43:669-73. [DOI: 10.1016/j.mpmed.2015.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
377 Liu K, Li WD, Du XL, Li CL, Li XQ. Comparison of Systemic Thrombolysis Versus Indirect Thrombolysis via the Superior Mesenteric Artery in Patients with Acute Portal Vein Thrombosis. Ann Vasc Surg. 2017;39:264-269. [PMID: 27671456 DOI: 10.1016/j.avsg.2016.06.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
378 Wu M, Schuster M, Tadros M. Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants. J Clin Transl Hepatol 2019;7:154-64. [PMID: 31293916 DOI: 10.14218/JCTH.2018.00057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
379 Valla DC, Cazals-Hatem D. Sinusoidal obstruction syndrome. Clin Res Hepatol Gastroenterol. 2016;40:378-385. [PMID: 27038846 DOI: 10.1016/j.clinre.2016.01.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
380 Tavabie O, Suddle AR. Lymphoma and hematological conditions: II. Sickle cell hepatopathy and other hematological diseases. Clin Liver Dis (Hoboken) 2016;8:6-9. [PMID: 31041054 DOI: 10.1002/cld.557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
381 Qi XS, Bai M, He CY, Yin ZX, Guo WG, Niu J, Wu FF, Han GH. Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: An 8-year retrospective single-center study. World J Gastroenterol 2013; 19(42): 7447-7454 [PMID: 24259977 DOI: 10.3748/wjg.v19.i42.7447] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
382 Trebicka J, Strassburg CP. Etiology and Complications of Portal Vein Thrombosis. Viszeralmedizin. 2014;30:375-380. [PMID: 26288604 DOI: 10.1159/000369987] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
383 Tang R, Tian X, Xie X, Yang Y. Intestinal Infarction Caused by Thrombophlebitis of the Portomesenteric Veins as a Complication of Acute Gangrenous Appendicitis After Appendectomy: A Case Report. Medicine (Baltimore). 2015;94:e1033. [PMID: 26091450 DOI: 10.1097/MD.0000000000001033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
384 Shang H, Bai T, Zhu S, Yang X, Liu C, Xu D, Zhuge Y, Song Y, Hou X. Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China. Ann Transl Med 2021;9:11. [PMID: 33553304 DOI: 10.21037/atm-20-731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
385 De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016;115:240-9. [PMID: 26333846 DOI: 10.1160/TH15-04-0326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
386 Martinez S, Garcia I, Ruiz A, Tàssies D, Reverter JC, Colmenero J, Beltran J, Fondevila C, Blasi A. Is antivitamin K reversal required in patients with cirrhosis undergoing liver transplantation? Transfusion 2021. [PMID: 34358342 DOI: 10.1111/trf.16607] [Reference Citation Analysis]
387 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179-202. [PMID: 26516032 DOI: 10.1016/j.jhep.2015.07.040] [Cited by in Crossref: 291] [Cited by in F6Publishing: 199] [Article Influence: 48.5] [Reference Citation Analysis]
388 Saugel B, Lee M, Feichtinger S, Hapfelmeier A, Schmid RM, Siveke JT. Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis. J Thromb Thrombolysis. 2015;40:54-60. [PMID: 25115839 DOI: 10.1007/s11239-014-1124-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
389 Nagaoki Y, Aikata H, Daijyo K, Teraoka Y, Shinohara F, Nakamura Y, Hatooka M, Morio K, Nakahara T, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Hepatol Res. 2018;48:51-58. [PMID: 28342265 DOI: 10.1111/hepr.12895] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 14.0] [Reference Citation Analysis]
390 Nicoletti V, Gioia S, Lucatelli P, Nardelli S, Pasquale C, Nogas Sobrinho S, Pentassuglio I, Greco F, De Santis A, Merli M, Riggio O. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors. Digestive and Liver Disease 2016;48:1072-7. [DOI: 10.1016/j.dld.2016.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
391 Eshkenazy R, Dreznik Y, Lahat E, Zakai BB, Zendel A, Ariche A. Small for size liver remnant following resection: prevention and management. Hepatobiliary Surg Nutr 2014;3:303-12. [PMID: 25392842 DOI: 10.3978/j.issn.2304-3881.2014.09.08] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
392 Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015;45:656-662. [PMID: 25088236 DOI: 10.1111/hepr.12400] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
393 Rinaldi F, Lissandrin R, Mojoli F, Baldanti F, Brunetti E, Pascarella M, Giordani MT. Acute cytomegalovirus infection as a cause of venous thromboembolism. Mediterr J Hematol Infect Dis 2014;6:e2014041. [PMID: 24959338 DOI: 10.4084/MJHID.2014.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
394 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
395 Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, Feng G, Xiong B. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2020;32:507-16. [PMID: 31658174 DOI: 10.1097/MEG.0000000000001586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 De Stefano V, Rossi E. Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost 2013;110:697-705. [PMID: 23846575 DOI: 10.1160/TH13-01-0011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 18] [Article Influence: 6.4] [Reference Citation Analysis]
397 Seedial SM, Mouli SK, Desai KR. Acute Portal Vein Thrombosis: Current Trends in Medical and Endovascular Management. Semin Intervent Radiol. 2018;35:198-202. [PMID: 30087523 DOI: 10.1055/s-0038-1660798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
398 Wang X, Lin SX, Tao J, Wei XQ, Liu YT, Chen YM, Wu B. Study of liver cirrhosis over ten consecutive years in Southern China. World J Gastroenterol 2014; 20(37): 13546-13555 [PMID: 25309085 DOI: 10.3748/wjg.v20.i37.13546] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
399 Mancuso A. Controversies in the Management of Budd–Chiari Syndrome. In: Qi X, editor. Budd-Chiari Syndrome. Singapore: Springer; 2020. pp. 245-52. [DOI: 10.1007/978-981-32-9232-1_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
400 Vuppalanchi R, Saxena R, Storniolo AMV, Chalasani N. Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib. Hepatology 2017;65:1762-4. [PMID: 27397671 DOI: 10.1002/hep.28720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
401 Hibi A, Mogi K. Portal vein thrombosis after cesarean section in a patient on prolonged bed rest due to threatened preterm labor. Clin Case Rep 2018;6:531-6. [PMID: 29531735 DOI: 10.1002/ccr3.1405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
402 Mohagheghi S, Khajehahmadi Z, Nikeghbalian S, Alavian SM, Doosti-Irani A, Khodadadi I, Karimi J, Sharafi H, Tavilani H. Changes in the distribution of etiologies of cirrhosis among patients referred for liver transplantation over 11 years in Iran. Eur J Gastroenterol Hepatol 2020;32:844-50. [PMID: 31688307 DOI: 10.1097/MEG.0000000000001590] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Wanless IR, Huang W. Vascular disorders. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 601-43. [DOI: 10.1016/b978-0-7020-3398-8.00012-x] [Cited by in Crossref: 16] [Article Influence: 1.8] [Reference Citation Analysis]
404 Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332-346. [PMID: 25755580 DOI: 10.1016/j.jceh.2014.10.002] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 18.3] [Reference Citation Analysis]
405 Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, Bai M, Niu J, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int. 2014;34:1164-1175. [PMID: 24256572 DOI: 10.1111/liv.12355] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
406 Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-38. [PMID: 22300463 DOI: 10.1016/S0168-8278(12)60004-X] [Cited by in Crossref: 132] [Cited by in F6Publishing: 38] [Article Influence: 14.7] [Reference Citation Analysis]
407 Soares S, Freitas AC, Rodrigues C, Lopes L, Carvalho C, Pereira S. A Large Tortuous Umbilical Cord with Superficial Abdominal Wall Varicose Veins in a Newborn. Neoreviews 2020;21:e774-7. [PMID: 33139517 DOI: 10.1542/neo.21-11-e774] [Reference Citation Analysis]
408 Kallini JR, Gabr A, Kulik L, Ganger D, Lewandowski R, Thornburg B, Salem R. Noncirrhotic complete obliterative portal vein thrombosis: Novel management using trans-splenic transjugular intrahepatic portosystemic shunt with portal vein recanalization: HEPATOLOGY, Vol. XX, No. X, 2016. Hepatology 2016;63:1387-90. [DOI: 10.1002/hep.28429] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
409 Li M, De Stefano V, Song T, Zhou X, Guo Z, Zhu J, Qi X. Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis. Thrombosis Research 2018;167:96-103. [DOI: 10.1016/j.thromres.2018.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
410 Abbattista M, Capecchi M, Martinelli I. Treatment of unusual thrombotic manifestations. Blood 2020;135:326-34. [PMID: 31917405 DOI: 10.1182/blood.2019000918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
411 Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, Deshmukh H, Cua IHY, Lesmana CRA, Al Meshtab M, Kage M, Chaiteeraki R, Treeprasertsuk S, Giri S, Punamiya S, Paradis V, Qi X, Sugawara Y, Abbas Z, Sarin SK. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021;15:531-67. [PMID: 34240318 DOI: 10.1007/s12072-021-10189-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Zhang L, Hu B, Li W, Huang P, Zhang S, Zhong B, Ni C. 125I Irradiation Stent for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis: A Systematic Review. Cardiovasc Intervent Radiol 2020;43:196-203. [DOI: 10.1007/s00270-019-02346-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
413 Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis. 2010;42:163-170. [PMID: 19766546 DOI: 10.1016/j.dld.2009.08.003] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 7.3] [Reference Citation Analysis]
414 Wang M, Wei A, Zhang Z, Peng B. Laparoscopic Splenectomy for the Elderly Liver Cirrhotic Patients With Hypersplenism: A Retrospective Comparable Study. Medicine (Baltimore) 2016;95:e3012. [PMID: 26962816 DOI: 10.1097/MD.0000000000003012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
415 Ponziani FR, Zocco MA, Tortora A, Gasbarrini A. Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? Expert Opin Pharmacother. 2010;11:1479-1487. [PMID: 20446862 DOI: 10.1517/14656561003749264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
416 Richardson PG, Ho VT, Cutler C, Glotzbecker B, Antin JH, Soiffer R. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions. Biol Blood Marrow Transplant 2013;19:S88-90. [PMID: 23089567 DOI: 10.1016/j.bbmt.2012.10.023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
417 Li LN, Sun XY, Wang GC, Tian XG, Zhang MY, Jiang KT, Zhang CQ. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival. J Dig Dis. 2019;20:89-96. [PMID: 30629804 DOI: 10.1111/1751-2980.12702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
418 Young LH, Henderson KJ, White RI, Garcia-tsao G. Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia. Hepatology 2013;58:442-5. [DOI: 10.1002/hep.26472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
419 Fallon MB, Batra S. Inherited thrombophilia and the risk of portal vein thrombosis: progress toward individualized anticoagulation in cirrhosis? Clin Gastroenterol Hepatol 2014;12:1813-4. [PMID: 25086188 DOI: 10.1016/j.cgh.2014.07.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
420 Campello E, Spiezia L, Simioni P. Diagnosis and management of factor V Leiden. Expert Rev Hematol. 2016;9:1139-1149. [PMID: 27797270 DOI: 10.1080/17474086.2016.1249364] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
421 Maillette de Buy Wenniger L, Beuers U. Bile salts and cholestasis. Dig Liver Dis. 2010;42:409-418. [PMID: 20434968 DOI: 10.1016/j.dld.2010.03.015] [Cited by in Crossref: 101] [Cited by in F6Publishing: 93] [Article Influence: 9.2] [Reference Citation Analysis]
422 Seijo S, Plessier A. Noncirrhotic nontumoral portal vein thrombosis. Clin Liver Dis (Hoboken) 2014;3:118-21. [PMID: 30992903 DOI: 10.1002/cld.336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
423 Suda T, Takatori H, Hayashi T, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Yamashita T, Yamashita T, Mizukoshi E, Honda M, Okumura K, Kozaka K, Kaneko S. Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis. Life (Basel) 2020;10:E177. [PMID: 32899804 DOI: 10.3390/life10090177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
424 Hammond JS, Guha IN, Beckingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. British Journal of Surgery 2011;98:1188-200. [DOI: 10.1002/bjs.7630] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 11.5] [Reference Citation Analysis]
425 Zhao M, Yue Z, Zhao H, Wang L, Fan Z, He F, Yao J, Dong X, Liu F. Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis. Sci Rep. 2016;6:33069. [PMID: 27620282 DOI: 10.1038/srep33069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
426 Bertoletti L, Benhamou Y, Béjot Y, Marechaux S, Cheggour S, Aleil B, Lellouche N, Dillinger J, Delluc A. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Reviews 2018;32:272-9. [DOI: 10.1016/j.blre.2018.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
427 Riva N, Ageno W. Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses. Thromb Res 2018;163:252-9. [PMID: 28673473 DOI: 10.1016/j.thromres.2017.06.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
428 Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol. 2011;9:936-946; quiz e123. [PMID: 21699820 DOI: 10.1016/j.cgh.2011.06.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
429 Khan F, Mehrzad H, Tripathi D. Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective. J Transl Int Med. 2018;6:97-104. [PMID: 30425945 DOI: 10.2478/jtim-2018-0022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
430 Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS. Redefining Budd-Chiari syndrome: A systematic review. World J Hepatol 2016; 8(16): 691-702 [PMID: 27326316 DOI: 10.4254/wjh.v8.i16.691] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
431 De Stefano V, Martinelli I. Abdominal thromboses of splanchnic, renal and ovarian veins. Best Pract Res Clin Haematol 2012;25:253-64. [PMID: 22959542 DOI: 10.1016/j.beha.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
432 Shalimar, Kumar A, Kedia S, Sharma H, Gamanagatti SR, Gulati GS, Nayak B, Thakur B, Acharya SK. Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score. Aliment Pharmacol Ther 2016;43:1154-67. [PMID: 27060876 DOI: 10.1111/apt.13604] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
433 Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN; Haemato-oncology Task Force of British Committee for Standards in Haematology., British Society for Blood and Marrow Transplantation. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 2013;163:444-57. [PMID: 24102514 DOI: 10.1111/bjh.12558] [Cited by in Crossref: 177] [Cited by in F6Publishing: 151] [Article Influence: 22.1] [Reference Citation Analysis]
434 Chammas MC, Oliveira AC, D Ávilla MJ, Moraes PH, Takahashi MS. Characterization of Malignant Portal Vein Thrombosis with Contrast-Enhanced Ultrasonography. Ultrasound Med Biol 2019;45:50-5. [PMID: 30366607 DOI: 10.1016/j.ultrasmedbio.2018.09.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
435 Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012;10:776-83. [PMID: 22289875 DOI: 10.1016/j.cgh.2012.01.012] [Cited by in Crossref: 232] [Cited by in F6Publishing: 195] [Article Influence: 25.8] [Reference Citation Analysis]
436 Wang Q, Li K, He C, Yuan X, Luo B, Qi X, Guo W, Bai W, Yu T, Fan J, Wang Z, Yuan J, Li X, Zhu Y, Han N, Niu J, Lv Y, Liu L, Li J, Tang S, Guo S, Wang E, Xia D, Wang Z, Cai H, Wang J, Yin Z, Xia J, Fan D, Han G. Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4:686-697. [PMID: 31279647 DOI: 10.1016/s2468-1253(19)30177-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]